US20240091461A1 - Compact injector systems and methods - Google Patents
Compact injector systems and methods Download PDFInfo
- Publication number
- US20240091461A1 US20240091461A1 US18/186,502 US202318186502A US2024091461A1 US 20240091461 A1 US20240091461 A1 US 20240091461A1 US 202318186502 A US202318186502 A US 202318186502A US 2024091461 A1 US2024091461 A1 US 2024091461A1
- Authority
- US
- United States
- Prior art keywords
- needle
- injector device
- view
- plunger
- housing portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title abstract description 18
- 238000002347 injection Methods 0.000 abstract description 44
- 239000007924 injection Substances 0.000 abstract description 44
- 238000003860 storage Methods 0.000 abstract description 3
- 208000012266 Needlestick injury Diseases 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 21
- 210000003811 finger Anatomy 0.000 description 21
- 238000007789 sealing Methods 0.000 description 19
- 239000012530 fluid Substances 0.000 description 12
- 230000035515 penetration Effects 0.000 description 10
- 230000007704 transition Effects 0.000 description 10
- 230000013011 mating Effects 0.000 description 9
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 8
- 238000013519 translation Methods 0.000 description 8
- 208000003455 anaphylaxis Diseases 0.000 description 7
- 206010002198 Anaphylactic reaction Diseases 0.000 description 6
- 230000036783 anaphylactic response Effects 0.000 description 6
- 238000004891 communication Methods 0.000 description 6
- 229940015979 epipen Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 229940124597 therapeutic agent Drugs 0.000 description 6
- 208000004262 Food Hypersensitivity Diseases 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 229920001903 high density polyethylene Polymers 0.000 description 4
- 239000004700 high-density polyethylene Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 206010016946 Food allergy Diseases 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- -1 enalapril) Chemical compound 0.000 description 3
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 3
- 229920002529 medical grade silicone Polymers 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- 229930182837 (R)-adrenaline Natural products 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 229960005139 epinephrine Drugs 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- SGUAFYQXFOLMHL-UHFFFAOYSA-N 2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide Chemical compound C=1C=C(O)C(C(N)=O)=CC=1C(O)CNC(C)CCC1=CC=CC=C1 SGUAFYQXFOLMHL-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 108010058207 Anistreplase Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- JRWZLRBJNMZMFE-UHFFFAOYSA-N Dobutamine Chemical compound C=1C=C(O)C(O)=CC=1CCNC(C)CCC1=CC=C(O)C=C1 JRWZLRBJNMZMFE-UHFFFAOYSA-N 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- DJBNUMBKLMJRSA-UHFFFAOYSA-N Flecainide Chemical compound FC(F)(F)COC1=CC=C(OCC(F)(F)F)C(C(=O)NCC2NCCCC2)=C1 DJBNUMBKLMJRSA-UHFFFAOYSA-N 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010069803 Injury associated with device Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229960003318 alteplase Drugs 0.000 description 1
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 1
- 229960005260 amiodarone Drugs 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 229960000983 anistreplase Drugs 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960002274 atenolol Drugs 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- YEESUBCSWGVPCE-UHFFFAOYSA-N azanylidyneoxidanium iron(2+) pentacyanide Chemical compound [Fe++].[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.N#[O+] YEESUBCSWGVPCE-UHFFFAOYSA-N 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- 108010034479 digoxin antibodies Fab fragments Proteins 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960001089 dobutamine Drugs 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 229940105367 epinephrine auto-injector Drugs 0.000 description 1
- 229960003745 esmolol Drugs 0.000 description 1
- AQNDDEOPVVGCPG-UHFFFAOYSA-N esmolol Chemical compound COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1 AQNDDEOPVVGCPG-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229960000449 flecainide Drugs 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960001632 labetalol Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 229960004127 naloxone Drugs 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 229960002460 nitroprusside Drugs 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940071643 prefilled syringe Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- REQCZEXYDRLIBE-UHFFFAOYSA-N procainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 REQCZEXYDRLIBE-UHFFFAOYSA-N 0.000 description 1
- 229960000244 procainamide Drugs 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 229960002917 reteplase Drugs 0.000 description 1
- 108010051412 reteplase Proteins 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960002370 sotalol Drugs 0.000 description 1
- ZBMZVLHSJCTVON-UHFFFAOYSA-N sotalol Chemical compound CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 ZBMZVLHSJCTVON-UHFFFAOYSA-N 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/322—Retractable needles, i.e. disconnected from and withdrawn into the syringe barrel by the piston
- A61M5/3234—Fully automatic needle retraction, i.e. in which triggering of the needle does not require a deliberate action by the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/46—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for controlling depth of insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3148—Means for causing or aiding aspiration or plunger retraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31513—Piston constructions to improve sealing or sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3213—Caps placed axially onto the needle, e.g. equipped with finger protection guards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/3245—Constructional features thereof, e.g. to improve manipulation or functioning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
- A61M5/5086—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile for indicating if defective, used, tampered with or unsterile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M2005/31518—Piston or piston-rod constructions, e.g. connection of piston with piston-rod designed to reduce the overall size of an injection device, e.g. using flexible or pivotally connected chain-like rod members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M2005/3208—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles by application of rotational movement to the needle hub, e.g. by use of electrically driven toothed wheels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/322—Retractable needles, i.e. disconnected from and withdrawn into the syringe barrel by the piston
- A61M5/3234—Fully automatic needle retraction, i.e. in which triggering of the needle does not require a deliberate action by the user
- A61M2005/3241—Needle retraction energy is accumulated inside of a hollow plunger rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/3245—Constructional features thereof, e.g. to improve manipulation or functioning
- A61M2005/3247—Means to impede repositioning of protection sleeve from needle covering to needle uncovering position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
- A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
- A61M2005/3261—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user triggered by radial deflection of the anchoring parts between sleeve and syringe barrel, e.g. spreading of sleeve retaining hooks having slanted surfaces by engagement with conically shaped collet of the piston rod during the last portion of the injection stroke of the plunger
Definitions
- Embodiments described herein relate to compact injector systems, apparatus, and methods. According to a 2015 survey conducted by the National Institute of Health, 1.6-5.1% of American adults are at risk for anaphylaxis, or roughly 4-12.75 million (Altman, Ashley M., et al. “Anaphylaxis in America: A national physician survey.” The Journal of Allergy and Clinical Immunology , U.S. National Library of Medicine, March 2015). This does not include the 4 to 6% of American children at risk, a percentage that is on the rise (Sifferlin, Alexandra. “What food allergies are costing families—and the economy.” CNN, Cable News Network, 21 Mar. 2014).
- Allergenic triggers vary, but of the population of Americans at risk for anaphylaxis: 34% are allergic to medications like penicillin and non-steroid anti-inflammatories, 31% are allergic to foods—most commonly peanuts, tree nuts, dairy, soy, eggs, and shellfish, and 20% of those at risk for anaphylaxis are allergic to bees or other insect stings (“Anaphylaxis in America AAAAI.” The American Academy of Allergy, Asthma & Immunology, 15 Oct. 2013). The average person with a life-threatening allergic reaction has ninety seconds to be delivered a life-saving dose of epinephrine before the throat closes and suffocation begins (anaphylaxis).
- EPIPEN® auto-injection devices
- EPIPEN® two-pack: auto-injection devices to be carried at all times and renewed each year.
- EPIPENS® dominate the market, they are unwieldy. When encased, they are each six inches long and over an inch wide. As a result, it is estimated that two-thirds of EPIPEN® users do not carry them on their person (“Sanofi Announces Auvi-QTM, the First and Only Voice-Guided Epinephrine Auto-Injector, is Now Available in the U.S.” Sanofi. 28 Jan. 2013).
- the EPIPEN® is intended to be exclusively administered in the upper thigh, and the spring inside an EPIPEN® delivers twenty pounds of force to ensure the needle can get through jeans. They are very painful and incite fear of use.
- Devices and methods may comprise a compact injector with a compact configuration for ease of carrying or storage, and an activated configuration ready for injection.
- the compact configuration may be approximately the size of a lip balm stick, such as a CHAPSTICK®, with a diameter of less than 20 mm and a length of less than 90 mm, 80 mm, or 70 mm, for example, though other diameters and lengths, including larger device, are also contemplated.
- a plunger and a needle are both retracted into the injector housing, and upon actuation to the activated configuration, the plunger extends proximally and the needle extends distally, ready for injection.
- An extendable needle shield is also provided to block visibility of the needle during injection, and to reduce the risk of inadvertent needle stick at other times, including disposal.
- an apparatus comprising a housing assembly, including a first housing portion and a second housing portion, the first housing portion and the second housing portion collectively defining a first interior cavity, an internal cartridge defining a reservoir, the internal cartridge at least partially disposed within the interior cavity, and a plunger assembly which includes a first plunger portion, a second plunger portion, and a sealing element, the second plunger portion defining a distal end wall, a sidewall, and a second interior cavity, the first plunger portion movably disposed within the second interior cavity, the second plunger portion slidably disposed within the reservoir of the internal cartridge, the sealing element coupled to the second plunger portion proximal of the distal end wall of the second plunger portion, the sealing element configured to sealingly couple the second plunger portion to the internal cartridge such that the reservoir is partially defined by the sealing element, wherein the first housing portion is configured to be rotated relative to the second housing portion between a first position and a second position, the first plunger portion prevented from being longitudinal
- first housing portion may further comprise a slot in the proximal end of the first housing portion and a retaining tab extending into the slot and the first plunger portion includes a latch, the latch being disposed within the slot and engaged with the retaining tab when the first housing portion is in the first position, the latch being disengaged from the retaining tab and translatable through the slot when the first housing portion is in the second position.
- the second plunger portion when the first housing portion is in the first position, the second plunger portion may be disposed within the reservoir such that a circumferential gap is defined between the sidewall of the second plunger portion and an inner surface of the internal cartridge and such that a space is defined between the distal end wall and a distal end of the internal cartridge, the circumferential gap being in fluid communication with the space.
- the second plunger portion may comprise a guide extending from the sidewall, the guide disposed between the distal end wall of the second plunger portion and the sealing element, the guide contacting an inner surface of the internal cartridge.
- the first plunger portion may further comprise at least one tab biased to expand axially from a first compressed configuration to a second projecting configuration relative to a central longitudinal axis of the first plunger portion when the first housing portion is in the second position and the first plunger portion has been longitudinally translated proximally relative to the first housing portion, and at least one tab may be configured to extend through a recess of the second plunger portion in the second projecting configuration.
- the apparatus may further comprise a needle and a needle sheath, the needle partially disposed within the reservoir, the needle sheath partially disposed within the first interior cavity, the needle sheath prevented from being longitudinally translated relative to the second housing portion when the first housing portion is in the first position, the needle sheath longitudinally translatable relative to the second housing portion when the first housing portion is in the second position.
- the needle sheath may include a projecting portion, the projecting portion engaged with a retaining surface of the second housing portion when the first housing portion is in the first position, and the projecting portion disengaged from the retaining surface of the second housing portion when the first housing portion is in the second position.
- the apparatus may also further comprise a spring having a first end and a second end, the first end of the spring coupled to the internal cartridge and a second end of the internal cartridge coupled to the needle sheath such that the needle sheath is biased toward an expanded position relative to the internal cartridge.
- the apparatus may also further comprise a needle cover, the needle sheath including a proximal end and a distal end, the needle including a proximal end and a distal end, the proximal end of the needle being disposed within the reservoir, the distal end of the needle and the distal end of the needle sheath coupled to the needle cover.
- the needle may comprise a hole proximate the distal end of the needle, the needle cover being coupled to the needle via a wire threaded through the hole.
- the apparatus may further comprise a catch disposed within the internal cartridge, the needle including an engagement portion, the engagement portion configured to engage with the catch upon distal translation of the needle relative to the internal cartridge.
- a distance from a distalmost portion of the needle cover to a proximalmost portion of the plunger may be less than about 90 mm when the first housing portion is in the first position, the first plunger portion is partially disposed within the second cavity, and the needle cover is coupled to the distal end of the needle sheath.
- the second plunger portion may comprise a proximal end, the sealing element being disposed proximate the proximal end of the second plunger portion.
- a method comprising rotating a first housing portion relative to a second housing portion such that a latch of a plunger is disengaged from a retaining tab of the second housing portion, an internal cartridge defining a reservoir at least partially disposed within a first interior cavity collectively defined by the first housing portion and the second housing portion, the plunger including a first plunger portion and a second plunger portion, the second plunger portion defining a second interior cavity, the first plunger portion movably disposed within the second interior cavity, the second plunger portion slidably disposed within the reservoir of the internal cartridge, proximally translating the first plunger portion relative to the second plunger portion and relative to the first housing portion such that at least one tab of the first plunger portion transitions from a first, compressed configuration to a second, projecting configuration, and distally translating the first plunger portion such that the at least one tab distally translates the second plunger portion within the internal cartridge.
- the rotating of the first housing portion relative to the second housing portion may be configured to cause a needle sheath to rotate from an engaged position to a disengaged position relative to the second housing portion and to distally translate relative to the second housing portion such that a needle cover coupled to a distal end of the needle sheath and coupled to a distal end of a needle disposed within the needle sheath distally translates the needle relative to the internal cartridge.
- the method may further comprise removing the needle cap such that the needle is further distally translated relative to the internal cartridge.
- an apparatus comprising a housing assembly including a first housing portion and a second housing portion, the first housing portion and the second housing portion collectively defining a first interior cavity, an internal cartridge defining a reservoir, the internal cartridge at least partially disposed within the first interior cavity, the internal cartridge including a catch, a plunger assembly slidably disposed within the reservoir of the internal cartridge, a needle sheath including a proximal end and a distal end, the proximal end of the needle sheath disposed within the first interior cavity, a needle including a proximal end and a distal end, the proximal end of the needle disposed within the reservoir, the needle including an engagement portion disposed within the reservoir, and a needle cover coupled to the distal end of the needle sheath and the distal end of the needle, the first housing portion configured to be rotated relative to the second housing portion between a first position and a second position, the needle sheath prevented from being longitudinally translated relative to the second housing portion when the
- the apparatus may be configured such that removal of the needle cover from the needle and the needle sheath distally translates the engagement portion of the needle relative to the catch feature of the internal cartridge.
- the apparatus may further comprise a seal, the plunger assembly including a distal end wall and a sidewall, the seal coupled to the sidewall of the plunger assembly proximal of the distal end wall of the plunger assembly, the seal in sealing contact with the internal cartridge such that the seal partial defines the reservoir.
- the plunger assembly may comprise a guide extending from the sidewall of the plunger assembly to the internal cartridge, the guide disposed on the sidewall of the plunger assembly between the seal and the distal end wall of the plunger assembly.
- a method of preparing an injector comprising removing an injector cap from an injector housing, pulling a needle out of a medicament cartridge located in the injector housing, twisting the injector housing to unlock an extendible plunger, and extending a needle sheath from the injector housing.
- the removal of the injector cap and the pulling of the needle may occur simultaneously.
- the pulling of the needle may be performed using a needle wire through a side hole of the needle, and wherein the needle wire is attached to the injector cap.
- an injection subassembly comprising a needle guide bushing, comprising a proximal end, a distal end with a needle catch interface, and a lumen therebetween, and a needle slidably located within the needle guide bushing, comprising a proximal end with a bushing catch interface complementary to the needle catch interface, a beveled distal end with a transverse opening, and longitudinal lumen between the proximal end and the distal end.
- the injection subassembly may further comprise a medicament cartridge, comprising a proximal end, a distal end and an internal cavity therebetween, and wherein the needle guide bushing resides within the internal cavity of the medicament cartridge and the distal end of the needle is located distal to the distal end of the medicament cartridge.
- the injection subassembly may further comprise a slidable stop within the internal cavity.
- the slidable seal may comprise a proximal surface accessible from the proximal end of the medicament cartridge, the proximal surface comprising a plunger interlocking interface.
- the plunger interface may be a helical screw interface.
- the injection subassembly may further comprise a syringe connector.
- the syringe connector may comprise a proximal friction interfit interface or a Luer connector.
- the syringe connector and the needle guide bushing may be integrally formed.
- the needle guide bushing may reside within the syringe connector.
- the bushing catch interface of the needle may comprise distally tapered barbs, and the needle catch interface of the needle guide bushing may comprise distally tapered internal ridges complemental to the distally tapered barbs.
- a method of injecting a therapeutic agent comprising removing an injector cap from an injector housing, pulling a needle out of a medicament cartridge located in the injector housing, twisting the injector housing to unlock an extendible plunger, extending a needle sheath from the injector housing, inserting the needle into an injection site, and depressing the plunger to deliver a therapeutic agent contained in the medicament cartridge.
- the removal of the injector cap and the pulling of the needle may occur simultaneously.
- the pulling of the needle may be performed using a needle wire through a side hole of the needle, and wherein the needle wire is attached to the injector cap.
- the injectors described herein may also be provided for use with any of a variety of clinical indications, therapeutic agents, and/or injection routes, and is not limited to ambulatory or emergency uses.
- the injector may also be used for intravenous or subcutaneous injection, or may comprise a Luer lock in place of a needle for connection to a peripheral or central venous line.
- the injector may be configured with a variety of therapeutic or diagnostic agents, including but not limited to agents for use in radiologic imaging, advanced cardiac life support, psychiatric settings, home antibiotic treatment for a variety of infection disease indications, etc.
- agents include but are not limited to haloperidol, chlorpromazine, lorazepam, morphine, codeine, adenosine, amiodarone, atropine, dopamine, lidocaine, magnesium, calcium chloride, procainamide, ACE inhibitors (e.g. enalapril), beta blockers (e.g. metoprolol, atenolol, propranolol, esmolol, labetalol, sotalol), DIGIBIND®, digoxin, dobutamine, fibrinolytic agents (e.g.
- FIGS. 1 A- 1 C are various views of an injector device, according to an embodiment.
- FIG. 2 is an exploded view of the injector device of FIG. 1 A .
- FIGS. 3 A- 3 G are various views of a cover of the injector device of FIG. 1 A in a first, attached configuration.
- FIGS. 3 H- 3 N are various views of the cover of FIGS. 3 A- 3 G in a second, detached configuration.
- FIGS. 4 A- 4 C are various views of a needle pull barb of the injector device of FIG. 1 A .
- FIGS. 5 A- 5 C are various views of a needle of the injector device of FIG. 1 A coupled to the cover of the injector device via the needle pull barb of the injector device.
- FIGS. 6 A- 6 E are various views of a needle sheath of the injector device of FIG. 1 A .
- FIGS. 7 A- 7 F are various views of a housing assembly of the injector device of FIG. 1 A .
- FIGS. 8 A- 8 F are various views of an internal cartridge of the injector device of FIG. 1 A .
- FIGS. 9 A- 9 C are a front view, a top view, and a perspective view, respectively, of a guide bushing of the injector device of FIG. 1 A .
- FIGS. 10 A- 10 C are a front view, a top view, and a perspective view, respectively, of a guide seal of the injector device of FIG. 1 A .
- FIGS. 11 A- 11 D are various views of the catch feature of the injector device of FIG. 1 A .
- FIGS. 12 A- 12 C are various views of the needle of the injector device of FIG. 1 A .
- FIGS. 13 A- 13 C are various views of the internal cartridge, the needle, the guide bushing, the guide seal, and the catch feature of the injector device of FIG. 1 A in an injection configuration in which the needle is engaged with the catch feature.
- FIGS. 14 A- 14 D are various views of a second plunger portion of a plunger assembly of the injector device of FIG. 1 A .
- FIGS. 15 A- 15 C are various views of a sealing element of the injector device of FIG. 1 A .
- FIGS. 16 A- 16 E are various views of a first housing portion of the injector device of FIG. 1 A .
- FIGS. 16 F- 16 J are various views of the second housing portion of the injector device of FIG. 1 A .
- FIGS. 17 A- 17 C are various views of the first plunger portion of the plunger assembly of the injector device of FIG. 1 A .
- FIGS. 18 A- 18 G are various views of the injector device of FIG. 1 A in a first, locked configuration.
- FIGS. 19 A- 19 G are various views of the injector device of FIG. 1 A in a second, unlocked configuration.
- FIGS. 20 A- 20 G are various views of the injector device of FIG. 1 A in a third, uncovered configuration.
- FIGS. 21 A- 21 G are various views of the injector device of FIG. 1 A in a fourth, extended or “ready” configuration.
- FIGS. 22 A- 22 D are various views of the injector device of FIG. 1 A disposed on a skin of a user prior to penetration.
- FIGS. 23 A- 23 D are various views of the injector device of FIG. 1 A in a fifth, penetration configuration.
- FIGS. 24 A- 24 E are various views of the injector device of FIG. 1 A in a sixth, injection configuration.
- FIG. 25 A- 25 E are various views of the injector device of FIG. 1 A in a seventh, withdrawn configuration.
- FIG. 26 is an exploded view of the injector device of FIG. 1 A included in a wearable injector assembly, according to an embodiment.
- FIG. 27 is an exploded view of the injector device of FIG. 1 A included in a wearable injector assembly, according to an embodiment.
- FIGS. 28 A- 28 G are various views of an injector device cover, according to an embodiment.
- FIGS. 29 A and 29 B are distal and proximal perspective views, respectively, of the injector device cover of FIGS. 28 A- 28 G coupled to an injector device, according to an embodiment.
- FIGS. 30 A- 30 E are various views of an injector device, according to an embodiment.
- FIGS. 31 A and 31 B are side elevational and longitudinal cross-sectional views, respectively of a separate needle hub assembly in a retracted configuration that may be used with a separate syringe.
- FIGS. 31 C and 31 D depict the needle hub assembly of FIGS. 31 A and 31 B in an extended position, respectively.
- the injection devices described herein are configured with a compact size so that the user can easily carry it or keep it close by, e.g. in a backpack, belt clip, bracelet or necklace, for example.
- the plunger When activated, the plunger can extend proximally and the needle can extend distally to facilitate injection of the medication.
- the length of the device in the compact or storage configuration may be in the range of about 60 mm to about 70 mm, about 50 mm to about 80 mm, or about 62 mm to about 66 mm.
- the diameter may be in the range of about 18 mm to about 26 mm, about 16 mm to about 31 mm, or about 21 mm to about 25 mm.
- the length may increase to be in a range of about 100 mm to about 110 mm, about 90 mm to about 120 mm, or about 103 mm to about 105 mm.
- the average diameter or largest axial cross-sectional dimension will not change, but in other examples, the diameter may also change to a size in the range of about 5 mm to about 18 mm, about 9 mm to about 28 mm, or about 19 mm to about 26 mm.
- the plunger may extend an additional distance from the injector housing of about 0.1 mm to about 8 mm, about 0.1 mm to about 11 mm, or about 0.5 mm to about 7 mm, while the needle may extend an additional distance from the injector housing in the range about 0.5 mm to about 8 mm, about 0.1 mm to about 11 mm, or about 1 mm to about 7 mm.
- FIGS. 1 A- 1 C are various perspective views of an injector device 100 shown in a locked configuration.
- the injector device 100 includes a housing assembly 110 , a plunger assembly 130 , a needle sheath 150 , and a cover 170 .
- the housing assembly 110 includes a first housing portion 115 and a second housing portion 120 .
- the first housing portion 115 is coupled to the second housing portion 120 such that the first housing portion 115 can be rotated relative to the second housing portion 120 to transition the injector device 100 between the locked configuration shown in FIGS. 1 A- 1 C and an unlocked configuration (shown, for example, in FIGS. 19 A- 19 G ).
- an unlocked configuration shown, for example, in FIGS. 19 A- 19 G .
- the first housing portion 115 can include ribs disposed on the outer surface of the first housing portion 115 to facilitate gripping of the first housing portion 115 by the user. Although shown as including ribs, the first housing portion 115 can include any suitable shape, features, or materials to facilitate gripping, such as a textured surface.
- the first housing portion 115 can include a positional indicator notch 111 .
- the second housing portion 120 can include a locked indicator notch 121 and an unlocked indicator notch 123 .
- the positional indicator notch 111 of the first housing portion 115 can be aligned with the locked indicator notch 121 of the second housing portion 120 , indicating to a user that the injector device 100 is in the locked configuration.
- the rotation of the first housing portion 115 relative to the second housing portion 120 can rotate the positional indicator notch 111 between alignment with the locked indicator notch 121 and alignment with the unlocked indicator notch 123 .
- the transition of the positional indicator notch 111 into alignment with the unlocked indicator notch 123 can also include tactile or auditory feedback, such as a snap sound.
- the first housing portion 115 can include a directional indicator 113 (e.g., an arrow), indicating the direction the first housing portion 115 can be rotated relative to the second housing portion 120 to transition the injector device 100 between the locked configuration and the unlocked configuration.
- the positional indicator notch 111 , the locked indicator notch 121 , the unlocked indicator notch 123 , and the directional indicator 113 can be included on the housing 110 via any suitable process or mechanism, such as by being molded with the housing 110 or via attachment of, for example, adhesive markers.
- the second housing portion 120 can include one or more windows 122 .
- the windows 122 can provide visual access to the contents of a reservoir (e.g., the reservoir 192 described below) such that the user can verify that the contents (e.g., medicine) are suitable for injection (e.g., the user can verify that the contents are unexpired based on color).
- the windows 122 can provide visual access to an outer wall of the needle sheath 150 .
- the outer wall of the needle sheath 150 can include a colored portion indicating a status of the injector device 100 (e.g., a green or red region indicating whether the injector device 100 is ready for use and/or penetration).
- FIG. 2 is an exploded view of the components of the injector device 100 .
- the plunger assembly 130 includes a first plunger portion 132 and a second plunger portion 134 .
- the injector device 100 also includes a needle 160 and a sealing element 140 .
- the injector device 100 further includes an internal cartridge 190 and a guide bushing 191 , a guide seal 193 , and a catch feature 195 disposed within the internal cartridge 190 .
- a spring 156 can be disposed within the needle sheath 150 and coupled to the internal cartridge 190 .
- a needle pull barb 180 can be engaged with the cover 170 and the needle 160 , as will be described below.
- FIGS. 3 A- 3 G are various views of the cover 170 in a first, attached configuration. Specifically, FIG. 3 A is a side view of the cover 170 , FIG. 3 B is a bottom view of the cover 170 , FIG. 3 C is a front view of the cover 170 , and FIG. 3 D is a top view of the cover 170 .
- FIG. 3 E is a cross-sectional view of the cover 170 taken along line A-A in FIG. 3 C .
- FIG. 3 F is a cross-sectional view of the cover 170 taken along line B-B in FIG. 3 C .
- FIG. 3 G is a perspective view of the cover 170 .
- the cover 170 includes a first tab 172 A, a second tab 172 B, and a stem 174 .
- the first tab 172 A and the second tab 172 B are arranged such that the stem 174 extends between the first tab 172 A and the second tab 172 B.
- FIGS. 3 H- 3 N are various views of the cover 170 in a second, detached configuration.
- FIG. 3 H is a side view of the cover 170
- FIG. 3 I is a bottom view of the cover 170
- FIG. 3 J is a front view of the cover 170
- FIG. 3 K is a top view of the cover 170
- FIG. 3 L is a cross-sectional view of the cover 170 taken along line A-A in FIG. 3 J
- FIG. 3 M is a cross-sectional view of the cover 170 taken along line B-B in FIG. 3 J
- FIG. 3 N is a perspective view of the cover 170 .
- the first tab 172 A and the second tab 172 B are arranged such that the first tab 172 A and the second tab 172 B extend away from the stem 174 .
- the cover 170 can be transitioned from the first, attached configuration to the second, detached configuration via, for example, folding the first tab 172 A and the second tab 172 B relative to the stem 174 .
- the cover 170 can be formed of any suitable material, such as molded rubber.
- a third or fourth tab may be provided, and/or the tabs may be longer and/or wider, to extend the full length of the injector, and may cover the proximal end of the injector, or entirely encapsulate the injector to provide additional safety and protection.
- FIGS. 28 A- 28 G are various views of a cover 270 .
- FIGS. 28 A and 28 B are a proximal perspective view and a distal perspective view of the cover 270 , respectively.
- FIGS. 28 C, 28 D , and 28 E are a first side view, a front view, and a second side view (opposite the first side) of the cover 270 , respectively.
- FIGS. 28 F and 28 G are a top or proximal view and a bottom or distal view of the cover 270 , respectively.
- the cover 270 can be similar in structure and/or function to the cover 170 .
- the cover 270 can include a base 278 including an internal stem 274 having the same structure and/or function to the internal stem 174 of the cover 170 .
- the cover 270 includes a first tab 272 A and a second tab 272 B.
- the first tab 272 A can optionally include an access flap 273 A and the second tab 272 B can optionally include an access flap 273 B.
- Each access flap 273 A and 273 B can be folded relative to the first tab 272 A and second tab 272 B, respectively.
- first tab 272 A can include an engagement flap 275 A and the second tab 272 B can include an engagement flap 275 B.
- the engagement flap 275 A and the engagement flap 275 B can be secured to each other via any suitable coupling mechanism.
- the engagement flap 275 A can include an engagement button 276 A and define an engagement opening (not shown).
- the engagement flap 275 B can include an engagement button 276 B and define an engagement opening (not shown).
- the engagement button 276 A can have a larger diameter than the engagement opening of the engagement flap 275 B and the engagement button 276 B can have a larger diameter than the engagement opening of the engagement flap 275 A.
- the engagement button 276 A can be inserted through and retained in the engagement opening of the engagement flap 276 B, and the engagement button 276 B can be inserted through and retained in the engagement opening of the engagement flap 276 A.
- the engagement flaps 275 A and 275 B can be reversibly secured via a single engagement button on one of the engagement flaps 275 A and 275 B and a single engagement opening on the other of the engagement flaps 275 A and 275 B.
- FIGS. 29 A and 29 B are a front or distal perspective view and a back or proximal perspective view of an injector device 200 including the cover 270 .
- the injector device 200 can be similar in structure and/or function to any of the injector devices described herein, such as injector device 100 .
- the injector device 200 can include a first plunger portion 232 , a first housing portion 215 , a second housing portion 220 , and a needle sheath 250 , which can be the same or similar in structure and/or function to the first plunger portion 132 , a first housing portion 115 , a second housing portion 120 , and a needle sheath 150 , respectively.
- the tabs 272 A and 272 B can extend from the base 278 of the cover 270 , which is coupled to the needle sheath 250 , along the sides of the first housing portion 215 and second housing portion 220 .
- the engagement flaps 275 A and 275 B can be secured to each other on the proximal side of the first plunger portion 232 . While the cover 270 is attached to the first housing portion 215 and the second housing portion and secured on the proximal side of the first plunger portion 232 , the access flaps 273 A and 273 B can be folded relative to the cover 270 such that windows on the second housing portion 220 can be viewed (e.g., to see the contents of an internal cartridge).
- the engagement flaps 275 A and 275 B can be disengaged from each other and the tabs 272 A and 272 B can be pulled distally relative to the first housing portion 215 and second housing portion 220 .
- the further use and deployment of the injector device 200 can proceed the same or similarly as described with respect to the injector device 100 .
- FIGS. 4 A- 4 C are various views of the needle pull barb 180 .
- FIG. 4 A is a perspective view of the needle pull barb 180
- FIG. 4 B is a front view of the needle pull barb 180
- FIG. 4 C is a side view of the needle pull barb 180 .
- the needle pull barb 180 can have a first end 182 and a second end 184 .
- the first end 182 can be embedded in the cover 170 and the second end 184 can be coupled to the needle 160 , as will be described in more detail below.
- the needle pull barb 180 can be formed of any suitable material and can be, for example, a stainless steel single strand wire or filament.
- FIGS. 5 A- 5 C are various views of the needle 160 coupled to the cover 170 via the needle pull barb 180 .
- FIG. 5 A is a side view
- FIG. 5 B is a cross-sectional view taken along line A-A in FIG. 5 A
- FIG. 5 C is a perspective view of the needle 160 coupled to the cover 170 via the pull barb 180 .
- the needle 160 can define a lumen 162 and a hole 161 (as described below with respect to FIGS. 12 A- 12 C ).
- the first end 182 of the needle pull barb 180 can be embedded in the cover 170 such that movement of the cover 170 can control movement of the needle pull barb 180 .
- the second end 184 of the needle pull barb 180 can be coupled to the needle 160 such that when a first force is applied to the cover 170 , the cover 170 can pull the needle 160 in the direction of the first force.
- a second force such as a resistive force
- the first force or a third force applied in the same direction as the first force
- the second end 184 of the needle pull barb 180 can be threaded through the lumen 162 of the needle 160 and out of the hole 161 .
- the second end 184 can then be folded relative to the needle 160 and/or embedded in the cover 170 .
- the cover 170 can pull on the barb 180 such that the barb 180 breaks proximate the location of the hole 161 in the needle 160 .
- the cover 170 can then be fully detached from the needle 160 , carrying the pieces of the barb 180 away from the needle 160 .
- the cover 170 can be formed of a material and sized such that the cover 170 can apply sufficient friction to the needle 160 to translate the needle 160 , but can detach from the needle 160 upon the application of a sufficient resistive or retaining force on the needle 160 in the opposite direction of the movement of the cover 170 .
- FIGS. 6 A- 6 E are various views of the needle sheath 150 .
- FIG. 6 A is a front view of the needle sheath 150
- FIG. 6 B is a side view of the needle sheath 150
- FIG. 6 C is a bottom view of the needle sheath 150
- FIG. 6 E is a top view of the needle sheath 150
- FIG. 6 D is a cross-sectional view of the needle sheath 150 taken along line A-A in FIG. 6 A .
- the needle sheath 150 includes a first, proximal end 151 and a second, distal end 153 .
- the needle sheath 150 includes a body 152 and projecting portions 154 .
- the needle sheath 150 can include two projecting portions 154 .
- the needle sheath 150 can include a number of indication regions 155 (e.g., one or two indication regions).
- the indication regions 155 can be disposed on the needle sheath 150 such that each indication region aligns with a window 122 of the housing assembly 110 when the injector device 100 is fully assembled and in the locked configuration.
- the indication regions 155 are transparent regions of the sidewall of the needle sheath 150 .
- the indication regions 155 are colored regions of the sidewall that indicate a status of the device.
- the indication regions 155 can be a first color, such as red, such that when the injector device 100 is in the locked configuration, the user can see a red indication region 155 through each window 122 of the housing assembly 110 , indicating that the device is locked and not ready for injection.
- the needle sheath 150 can include additional indicator regions or can be colored in regions outside of the indication regions 155 in a second color, such as green, such that when the needle sheath 150 is extended relative to the housing assembly 110 , the user can see a green region through each window 122 of the housing assembly 110 , indicating that the device is ready for operation.
- a second color such as green
- FIGS. 7 A- 7 F are various views of the housing assembly 110 .
- FIG. 7 A is a front view of the housing assembly 110
- FIG. 7 B is a side view of the housing assembly 110
- FIG. 7 C is a top view of the housing assembly 110
- FIG. 7 D is a side view opposite the side view of FIG. 7 B of the housing assembly 110
- FIG. 7 F is a bottom view of the housing assembly 110
- FIG. 7 E is a cross-sectional view of the housing assembly 110 taken along line A-A in FIG. 7 A .
- the housing assembly 110 include the first housing portion 115 and the second housing portion 120 .
- the second housing portion 120 can be shaped to define two recesses 124 in the outer surface of the second housing portion 120 . As shown in FIG. 7 E , the first housing portion 115 and the second housing portion 120 can collectively define an interior cavity 116 .
- the first housing portion 115 and the second housing portion 120 can be coupled via any suitable coupling mechanism that allows for the first housing portion 115 to be rotated relative to the second housing portion 120 .
- the first housing portion 115 and the second housing portion 120 can be coupled via a circlip or via an expandable spring within a groove of the first housing portion 115 or the second housing portion 120 .
- two slots 119 can be defined in a proximal end wall of the first housing portion 115 (also shown in FIG. 16 B ). Additionally, the first housing portion 115 can include a retaining tab 118 extending into each slot 119 .
- FIGS. 30 A- 30 E are various views of an injector device 300 .
- the injector device 300 can be the similar in structure and/or function to any of the injector devices described herein, such as the injector device 100 .
- the injector device 300 can include a housing assembly 310 including a first housing portion 315 and a second housing portion 320 , a needle sheath 350 , a cover 370 , a plunger assembly 330 , an internal cartridge 390 , and a needle 360 , which can be the same or similar in structure and/or function to the housing assembly 110 including a first housing portion 115 and a second housing portion 120 , a needle sheath 150 , a cover 170 , a plunger assembly 130 , an internal cartridge 190 , and a needle 160 , respectively.
- the injector device 300 can include a first finger handle 325 A and a second finger handle 325 B coupled to the second housing portion 320 .
- the first finger handle 325 A and the second finger handle 325 B can be rotated relative to the second housing portion 320 between an undeployed and a deployed configuration.
- the finger handles 325 A and 325 B can be disposed against the second housing portion 320 within the recesses 324 of the second housing portion 320 .
- the first finger handle 325 A can define an opening 326 A and the second finger handle 325 B can defined an opening 326 B such that, in the undeployed configuration, the windows 322 of the second housing portion 320 are not obstructed by the first finger handle 325 A and the second finger handle 325 B.
- the finger handles 325 A and 325 B can project laterally from the housing 320 such that a user's fingers can be placed into engagement with the distal side of the finger handles 325 A and 325 B during injection.
- the finger handles 325 A and 325 B can be transitioned from the undeployed to the deployed configuration manually by a user.
- each of the finger handles 325 A and 325 B can automatically transition from the undeployed to the deployed configuration via a spring (not shown).
- the finger handles 325 A and 325 B can automatically deploy after the cover tabs are disengaged from the finger handles 325 A and 325 B.
- FIGS. 8 A- 8 F are various views of the internal cartridge 190 .
- FIG. 8 A is a front view of the internal cartridge 190
- FIG. 8 B is a side view of the internal cartridge 190
- FIG. 8 C is a top view of the internal cartridge 190
- FIG. 8 D is a side view opposite the side view of FIG. 8 B of the internal cartridge 190
- FIG. 8 F is a bottom view of the internal cartridge 190
- FIG. 8 E is a cross-sectional view of the internal cartridge 190 taken along line A-A in FIG. 8 A .
- the internal cartridge 190 includes a stepped outlet 194 and one or more mating features 199 .
- the internal cartridge 190 can include three mating features 199 on each side of the internal cartridge 190 such that the internal cartridge 190 is configured to engage with the housing assembly 110 via the mating features 199 . Additionally, the internal cartridge 190 can define a reservoir 192 configured to hold medicament for injection by the injector device 100 .
- FIGS. 9 A- 9 C are a front view, a top view, and a perspective view, respectively, of a guide bushing 191 .
- the guide bushing 191 can be shaped and sized to be disposed within the outlet 194 of the internal cartridge 190 .
- the guide bushing 191 can define a lumen 186 .
- the outer diameter of the lumen 186 can be similar to the outer diameter of the needle 160 such that the guide bushing 191 can assist in directing the needle 160 along a central longitudinal axis of the injector device 100 as the needle 160 is translated distally.
- the guide bushing 191 may have a length in the range of about 6 mm to about 15 mm, or about 5 mm to about 18 mm.
- FIGS. 10 A- 10 C are a front view, a top view, and a perspective view, respectively, of a guide seal 193 .
- the guide seal 193 defines a central opening 193 A and is shaped and sized to be disposed in the outlet 194 of the internal cartridge 190 .
- the central opening 193 A of the guide seal 193 can be shaped and sized to provide a seal around the needle 160 such that fluid in the reservoir 192 of the internal cartridge 190 does not leak from the internal cartridge 190 proximate the outlet 194 .
- the guide seal 193 can form a distal boundary of the reservoir 192 .
- FIGS. 11 A- 11 B are various views of the catch feature 195 .
- FIG. 11 A is a front view of the catch feature 195
- FIG. 11 B is a top view of the catch feature 195
- FIG. 11 C is a perspective view of the catch feature 195
- FIG. 11 D is a cross-sectional view taken along line A-A in FIG. 11 A .
- the catch feature 195 defines a lumen 195 A.
- the inner wall of the catch feature 195 surrounding the lumen 195 A includes barbs 197 .
- the barbs 197 can be shaped such that a distal-facing surface of each barb 197 is perpendicular to a central longitudinal axis of the catch feature 195 running through the lumen 195 A, and a proximal surface of each barb 197 is angled relative to the distal-facing surface.
- an engagement feature 168 shown and described in FIGS. 12 A- 12 C
- the catch feature 195 can be formed of any suitable material and by any suitable process.
- the catch feature 195 can be molded or machined in high-density nylon.
- FIGS. 12 A- 12 C are various views of the needle 160 .
- FIG. 12 A is a front view of the needle 160
- FIG. 12 B is a side view of the needle 160
- FIG. 12 C is a cross-sectional view of the needle 160 taken along line A-A in FIG. 12 A .
- the needle 160 has a first end 165 , a second end 163 , and defines a lumen 162 extending from the first end 165 to the second end 163 .
- the needle 160 can define a number of inlets 164 in fluid communication with the lumen 162 .
- the second end 163 of the needle 160 can include a needle tip and an outlet 166 .
- the needle 160 can define a hole 161 for engagement with the needle pull barb 180 .
- the needle 160 can include an engagement feature 168 proximate the first end 165 of the needle 160 .
- the engagement feature 168 can include a number of engagement portions shaped to engage with the barbs 197 of the catch feature 195 such that the needle 160 can be moved distally relative to the catch feature 195 but is prevented from moving proximally.
- FIGS. 13 A- 13 C are various views of the internal cartridge 190 , the needle 160 , the guide bushing 191 , the guide seal 193 , and the catch feature 195 in an injection configuration in which the engagement feature 168 of the needle 160 is engaged with the catch feature 195 .
- FIG. 13 A is a front view
- FIG. 13 B is a cross-sectional view taken along line A-A of FIG. 13 A
- FIG. 13 C is a top view.
- the distance from the proximal end of the internal cartridge 190 to the distal end of the needle 160 can be a length L1.
- the needle 160 can have a length L2.
- the injection depth of the needle 160 relative to the skin can be L3.
- the length L1 can be, for example, about 3.22 inches.
- the length L2 can be, for example, about 1.7 inches.
- the length L3 can be, for example, about 0.9 inches.
- the internal cartridge 190 can have an inner diameter D1 and an outer diameter D2.
- the inner diameter D1 can be, for example, about 0.355 inches.
- the outer diameter D2 can be, for example, about 0.434 inches.
- the needle assembly 400 may be provided on a separate needle hub 402 that is attachable to a separate syringe or medicament cartridge 426 .
- the separate syringe may be a standardized syringe or a customized syringe or cartridge.
- the needle hub 402 include one or more internal cavities 404 , 406 with an attachment interface 408 , such as a male Luer interface that is attachable to the distal end of a syringe. Any of a variety of other attachment interfaces may be used, including a female Luer or a friction fit, for example. In the embodiment depicted in FIGS.
- the needle 410 slidably resides in a needle lumen 412 and the cavity 404 , 406 of the hub 402 .
- a needle catch structure 414 is also provided with the needle lumen 412 to receive the corresponding and complementary bushing or hub catch structure 416 that is located on the proximal end 418 of the needle 410 , as shown in FIGS. 31 C and 31 D .
- the needle 410 may also include a transverse or side opening 420 to receive a pull wire and cap as described elsewhere herein.
- the needle lumen 412 and the needle catch structure 414 are provided on a bushing 422 located in the distal cavity 404 of the assembly 400 .
- the bushing 422 is retained in the distal cavity 404 by a cap 424 .
- the cap 424 may be threadably attached to the rest of the hub 402 , but in other examples may be welded or bonded to the hub, or attached by other mechanical interfaces.
- the needle lumen may be integrally formed with the hub and a bushing and/or cap is not used.
- a guide bushing, a guide seal, and a catch feature maybe provided inside a single cavity of the needle hub, similar to the embodiments depicted in FIG. 2 .
- the needle hub assembly 400 may be provided as a separate product, optionally with a pull wire and cap, and/or outer housing components as described elsewhere herein, to a contract manufacturer of a prefilled syringe or medicament cartridge, as part of the manufacturing, assembly or packaging process of the device.
- the internal cavity 428 of the syringe 426 may be filled with the therapeutic agent prior to attachment of the needle hub 402 and may include a slidable seal 430 that may be engaged or coupled to the distal end of a plunger rod (not shown) at an engagement structure 432 during use or during manufacture in order to dispense the therapeutic agent when the slidable seal 430 is displaced distally.
- FIGS. 14 A- 14 D are various views of the second plunger portion 134 of the plunger assembly 130 .
- FIG. 14 A is a front view of the second plunger portion 134 .
- the second plunger portion 134 includes a distal end wall 139 and a sidewall 138 .
- the second plunger portion 134 also includes a guiding feature 136 .
- the guiding feature 136 can maintain the axial alignment of the rubber seal 140 , the first plunger portion 138 and/or second plunger portion 134 within the internal cartridge 190 such that the second plunger portion 134 is disposed on and translates along a central axis of the injection device 100 .
- the guiding feature 136 defines recesses 136 A such that fluid can flow from an area on a first side of the guiding feature 136 to an area on a second side of the guiding feature 136 .
- the guiding feature may be located at the distal end of the second plunger portion 134 or proximal to the distal end of the second plunger portion 134 , e.g. at a location 10%, 20%, 30%, 40%, or 50%, of the length of the length of the second plunger portion 134 , relative to the distal end of the plunger portion 134 , for example.
- the second plunger portion 134 defines a seal recess 189 near the proximal end of the second plunger portion 134 .
- the seal recess 189 is shaped and sized to receive the sealing element 140 .
- the second plunger portion 134 also defines four tab recesses 185 near the proximal end of the second plunger portion 134 .
- FIG. 14 B is a front view of the second plunger portion 134 in combination with the sealing element 140 .
- FIG. 14 C is a cross-sectional view of the second plunger portion 134 in combination with the sealing element 140 taken along line A-A in FIG. 14 B .
- FIG. 14 D is a top view of the second plunger portion 134 in combination with the sealing element 140 .
- the second plunger portion 134 includes an internal compartment 187 defining an interior cavity 198 .
- the internal compartment 187 can be shaped and sized to receive the proximal end of the needle 160 in the locked configuration of the injector device 100 .
- the internal compartment 187 can be formed of a substantially cylindrical internal sidewall and a proximal end wall.
- the interior cavity 198 defined by the internal compartment 187 can be in fluid communication with the interior of the internal cartridge 190 and can thus form a boundary of the reservoir 192 .
- the second plunger portion 134 can define four guide recesses 188 on an inner surface of the second plunger portion 134 .
- a tab recess 185 is disposed in each guide recess 188 .
- FIGS. 15 A- 15 C are various views of the sealing element 140 .
- FIG. 15 A is a front view of the sealing element 140
- FIG. 15 B is a top view of the sealing element 140
- FIG. 15 C is a perspective view of the sealing element 140 .
- the sealing element 140 can be formed of any suitable material configured to provide a seal between the second plunger portion 132 and the internal wall of the internal cartridge 190 .
- FIGS. 16 A- 16 E are various views of the first housing portion 115 .
- FIG. 16 A is a front view of the first housing portion 115
- FIG. 16 B is a top view of the first housing portion 115
- FIG. 16 C is a bottom view of the first housing portion 115
- FIG. 16 D is a perspective view of the first housing portion 115
- FIG. 16 E is a cross-sectional view of the first housing portion 115 taken along line A-A in FIG. 16 A .
- the first housing portion 115 defines a proximal opening 112 .
- the first housing portion 115 includes two retaining portions 114 extending inward from an internal wall of the first housing portion 115 .
- FIGS. 16 F- 16 J are various views of the second housing portion 120 .
- FIG. 16 F is a top view of the second housing portion 120
- FIG. 16 G is a perspective view of the second housing portion 120
- FIG. 16 H is a front view of the second housing portion 120
- FIG. 16 I is a side view of the second housing portion 120
- FIG. 16 J is a cross-sectional view of the second housing portion 120 taken along line A-A in FIG. 16 I .
- the second housing portion 120 includes two mating elements 129 . Each mating element 129 defines three recesses 129 A.
- Each of the recesses 129 A is configured to align with and engage with a mating feature 199 of the internal cartridge 190 such that the internal cartridge 190 and the second housing portion 120 are fixed relative to each other during operation of the injector device 100 .
- the internal cartridge 190 can be coupled to the second housing portion 120 via, for example, ultrasonic welding, solvent bonding, adhesive bonding, and the like
- FIGS. 17 A- 17 C are various views of the first plunger portion 132 .
- FIG. 17 A is a front view of the first plunger portion 132 and
- FIG. 17 B is a side view of the first plunger portion 132 .
- FIG. 17 C is a cross-sectional view of the first plunger portion 132 taken along line A-A in FIG. 17 A .
- the first plunger portion 132 includes a pad 131 and a stem 135 extending distally from the pad 131 .
- the first plunger portion 132 also includes two latches 133 extending distally from the distal surface of the pad 131 .
- the first plunger portion 132 includes four tabs 137 projecting from a sidewall of the stem 135 .
- the tabs 137 can be biased outward from the sidewall of the stem 135 and/or from the central axis of the first plunger portion 132 .
- the tabs 137 can also be shaped and sized such that the tabs 137 can be disposed within the guide recesses 188 of the second plunger portion 134 when the first plunger portion 132 is disposed within the second plunger portion 134 .
- the tabs 137 can also be flexible such that when the injector device 100 is in a locked configuration and the first plunger portion 132 is disposed within the second plunger portion 134 , the tabs 137 are compressed by the inner sidewall of the first plunger portion 132 .
- the tabs 137 can translate within the guide recesses 188 .
- the tabs 137 can automatically transition from the compressed position to an expanded position in which the tabs 137 extend into or through the tab recesses 185 .
- any distal translation of the first plunger portion 132 can apply a force to the second plunger portion 134 and translate the second plunger portion 134 .
- the first plunger portion 132 can include an indicator line 148 on the stem 135 .
- the indicator line 148 can be, for example, green in color.
- FIGS. 18 A- 18 G are various views of the injector device 100 in the first, locked configuration.
- FIG. 18 A is a front view of the injector device 100 in the first, locked configuration.
- FIG. 18 B is a cross-sectional view taken along line A-A of FIG. 18 A .
- FIG. 18 C is a side view of the injector device 100 in the first, locked configuration.
- FIG. 18 D is a cross-sectional view taken along line B-B of FIG. 18 C .
- FIG. 18 E is a top view of the injector device 100 of FIG. 18 C .
- FIG. 18 F is a cross-sectional view of the injector device 100 taken along line G-G of FIG. 18 E .
- FIG. 18 A is a front view of the injector device 100 in the first, locked configuration.
- FIG. 18 B is a cross-sectional view taken along line A-A of FIG. 18 A .
- FIG. 18 C is a side view of the injector device 100 in the first
- the length of the injector device 100 in the first, locked configuration (e.g., from the proximal surface of the first plunger portion 132 to the distal surface of the cover 170 ) can be equal to or less than about 3 inches.
- the positional indicator notch 111 is aligned with the closed indicator notch 121 when the injector device 100 is in the first, locked configuration.
- the reservoir 192 is defined by the guide seal 193 , the internal cartridge 190 , the sealing element 140 , and the second plunger portion 134 .
- the reservoir 192 can include a cylindrical gap portion 141 between the sidewall 138 of the second plunger portion 134 and an inner surface of the internal cartridge 190 .
- the reservoir 192 also includes the interior cavity 198 defined by the internal compartment 187 of the second plunger portion 134 .
- the recesses 188 of the guiding feature 136 shown in FIG.
- the needle 160 is in an initial position relative to the catch feature 195 such that the first end 165 of the needle 160 is disposed within the interior cavity 198 defined by the internal compartment 187 of the second plunger portion 134 .
- the first end 165 of the needle 160 is disposed within the reservoir 192 , with the lumen 162 of the needle 160 in fluid communication with the reservoir 192 , when the injector device 100 is in the first, locked configuration.
- the spring 156 is compressed between the distal end wall of the needle sheath 150 and the distal end wall of the internal cartridge 190 , the needle sheath is prevented from extending distally relative to the housing assembly 110 due to the abutment between the projecting portions 154 of the needle sheath 150 and the retaining portions 114 of the first housing portion 115 .
- the proximal retaining tab 118 (shown in FIG. 16 B ) is engaged with the latch 133 of the first plunger portion 132 such that the latch 133 , and thus the first plunger portion 132 , is prevented from being translated proximally relative to the housing assembly 110 .
- FIGS. 19 A- 19 G are various views of the injector device 100 in the second, unlocked configuration.
- FIG. 19 A is a front view of the injector device 100 in the second, unlocked configuration and
- FIG. 19 B is a cross-sectional view of the injector device 100 taken along line E-E of FIG. 19 A .
- FIG. 19 C is a side view of the injector device 100 in the second, unlocked configuration and
- FIG. 19 D is a cross-sectional view of the injector device 100 taken along line F-F of FIG. 19 C .
- FIG. 19 E is a top view of the injector device 100 of FIG. 19 C .
- FIG. 19 F is a cross-sectional view of the injector device 100 taken along line H-H of FIG. 19 E .
- FIG. 19 G is a cross-sectional view of the injector device 100 taken along line G-G of FIG. 19 E .
- the first housing portion 115 can be rotated relative to the second housing portion 120 .
- the positional indicator notch 111 is aligned with the open indicator notch 123 when the injector device 100 is in the second, unlocked configuration.
- the rotation of the first housing portion 115 relative to the second housing portion 120 rotates the retaining portions 114 of the first housing portion 115 out of alignment with the projecting portions 154 of the needle sheath 150 .
- the needle sheath 150 can be distally translated relative to the housing assembly 110 .
- the projecting portions 154 can be translated distally by the spring 156 .
- the distal translation of the needle sheath 150 by the spring 156 also distally translates the cover 170 coupled to the distal end of the needle sheath 150 . Due to the cover 170 being coupled to the needle 160 via the needle pull barb 180 , the distal translation of the cover 170 by the needle sheath 150 also distally translates the needle 160 from the initial position relative to the catch feature 195 to an intermediate position in which the engagement portion 168 of the needle 160 is coupled to the catch feature 195 , as shown, for example, in FIG. 19 B .
- the engagement portion 168 of the needle 160 can be in contact with the catch feature 195 in the intermediate position. In some embodiments, the engagement portion 168 of the needle 160 can be engaged with one or more barbs 197 of the catch feature 195 in the intermediate position.
- the rotation of the first housing portion 115 relative to the second housing portion 120 rotates the slots 119 and proximal retaining tabs 118 of the first housing portion 115 relative to the latching feature 133 of the first plunger portion 132 .
- the latching feature 133 is aligned with the slots 119 of the first housing portion 115 and unobstructed from proximal translation by the proximal retaining tabs 118 .
- FIGS. 20 A- 20 G are various views of the injector device 100 in a third, uncovered configuration.
- FIG. 20 A is a front view of the injector device 100 in the third, uncovered configuration
- FIG. 20 B is a cross-sectional view of the injector device 100 taken along line A-A in FIG. 20 A
- FIG. 20 C is a side view of the injector device 100 in the third, uncovered configuration
- FIG. 20 D is a cross-sectional view of the injector device 100 taken along line L-L in FIG. 20 C
- FIG. 20 E is a top view of the injector device 100 of FIG. 20 C .
- FIG. 20 F is a cross-sectional view of the injector device 100 taken along line M-M in FIG. 20 E .
- FIG. 20 G is a cross-sectional view of the injector device 100 taken along line N-N in FIG. 20 E .
- the injector device 100 can be transitioned from the second, unlocked configuration to the third, uncovered configuration by removing the cover 170 .
- the cover 170 can be transitioned to the detached configuration by, for example, rotating the tabs 172 and pulling the tabs 172 distally in the direction of arrow Z-Z away from the needle sheath 150 .
- the removal of the cover 170 from the needle sheath 150 and the second end 163 of the needle 160 translates the needle 160 distally from the intermediate position to an engaged position in which the engagement feature 168 of the needle 160 is fully engaged with the catch feature 195 .
- the engagement feature 168 is engaged with the barbs 197 of the catch feature 195 .
- the first end 165 of the needle 160 is disposed within the reservoir 192 such that the lumen 162 of the needle 160 is in fluid communication with the reservoir 192 when the needle 160 is in the engaged position and the injector device 100 is in the third, uncovered configuration.
- FIGS. 21 A- 21 G are various views of the injector device 100 in a fourth, extended or “ready” configuration.
- FIGS. 21 A and 21 B are a side view and a back view, respectively, of the injector device 100 in the fourth, extended configuration.
- FIG. 21 C is a top view of the injector device 100 as shown in FIG. 21 A .
- FIG. 21 D is a cross-sectional view of the injector device 100 taken along line A-A of FIG. 21 C .
- FIG. 21 E is a cross-sectional view of the injector device 100 taken along line L-L of FIG. 21 C .
- FIG. 21 F is a cross-sectional view of the injector device 100 taken along line N-N of FIG. 21 C .
- FIG. 21 G is a cross-sectional view of the injector device 100 taken along line M-M of FIG. 21 C .
- the first plunger portion 132 can be proximally translated relative to the housing assembly 110 .
- the transition of the first housing portion 115 between the first, locked configuration and the second, locked configuration rotates the proximal retaining tabs 118 out of obstructing alignment with the latching features 133 of the first plunger portion 132 .
- the first plunger portion 132 can be proximally translated (e.g., via pulling on the pad 131 ) relative to the second plunger portion 132 and the housing assembly 110 .
- the tabs 137 extending from the stem 135 of the first plunger portion 132 can slide within the guide recesses 188 of the second plunger portion 134 until the tabs 137 reach the tab recesses 185 of the second plunger portion 134 .
- the tabs 137 can transition from the compressed position to the expanded position, moving into or through the tab recesses 185 . In such a configuration, the injector device 100 is ready to be disposed on the skin of the user for the injection process.
- visibility of the indicator line 148 on the stem 135 of the first plunger portion 132 proximal of the first housing portion 115 and/or an auditory and/or tactile snap can indicate that the first plunger portion 132 has been sufficiently proximally translated relative to the housing assembly 110 .
- the indicator line 148 may be a green region with the same color as the window 122 , to indicate when the device is ready for use.
- FIGS. 22 A- 22 D are various views of the injector device 100 disposed on a skin S (e.g., skin on the arm or the leg) of a user prior to penetration.
- FIGS. 22 A, 22 B, and 22 C are a front view, a back view, and a side view, respectively, of the injector device 100 in the fourth, extended or ready configuration disposed on the skin S of a user.
- FIG. 22 D is a cross-sectional view of the injector device 100 taken along line T-T of FIG. 22 C .
- the injector device 100 is ready for injection.
- the injector device 150 can be aligned with the skin S such that the needle 160 is substantially perpendicular to the skin S.
- the spring 156 within the needle sheath 150 can maintain the distal end 153 of the needle sheath 150 against the skin S of the patient during the penetration and injection process.
- the needle sheath 150 in combination with the spring 156 can also assist the user in aligning the needle 160 with the skin S such that the needle 160 is substantially perpendicular to the skin S. Furthermore, the needle sheath 150 can obstruct the view of the needle 160 by the user, reducing stress and/or anxiety associated with the sight of the needle 160 .
- FIGS. 23 A- 23 D are various views of the injector device 100 in a fifth configuration in which the needle 160 has penetrated the skin S of the user.
- FIG. 23 A is a front view of the injector device 100 in a penetration configuration.
- FIG. 23 B is a cross-sectional view taken along line U-U of FIG. 23 A .
- FIG. 23 C is a side view of the injector device 100 in a penetration configuration.
- FIG. 23 D is a cross-sectional view taken along line V-V of FIG. 23 C .
- the injector device 100 can be transitioned from the fourth, extended configuration to the fifth, penetration configuration by distally translating the housing assembly 110 against the force of the spring 156 relative to the needle sheath 150 (i.e., toward the skin S). Due to the internal cartridge 190 being fixedly coupled to the second housing portion 120 via the mating features 199 , distal movement of the housing assembly 110 distally translates the internal cartridge 190 . Additionally, due to the engagement between the engagement portion 168 of the needle 160 and the barbs 197 of the catch feature 195 , distal translation of the internal cartridge 190 toward the skin S distally translates the needle 160 through the skin S.
- FIGS. 24 A- 24 E are various views of the injector device 100 in a sixth configuration in which the medicament has been injected from the reservoir 192 into the user.
- FIG. 24 A is a back view of the injector device 100 in the sixth configuration
- FIG. 24 B is a front view of the injector device 100 in the sixth configuration.
- FIG. 24 C is a cross-sectional view of the injector device 100 taken along line W-W of FIG. 24 B .
- FIG. 24 D is a side view of the injector device 100 in the sixth configuration.
- FIG. 24 E is a cross-sectional view of the injector device 100 taken along line X-X of FIG. 24 D .
- the injector device 100 can be transitioned from the fifth, penetration configuration to the sixth, injection configuration by distally translating the first plunger portion 132 relative to the housing assembly 110 such that the first plunger portion 132 distally translates the second plunger portion 134 .
- the distal translation of the second plunger portion 134 can push fluid within the reservoir 192 into the inlets 164 of the needle 160 such that the fluid flows through the lumen 162 of the needle, from the outlet 166 of the needle 160 , and into the user (e.g., into the surrounding tissue).
- the first plunger portion 132 can be distally translated relative to the housing assembly 110 , for example, by the user pressing on the pad 131 of the first plunger portion 132 with a finger (e.g., a thumb).
- a finger e.g., a thumb
- the user can use any suitable grip to hold the injector device during the penetration and injection process.
- the user can place a finger in engagement on opposing sides of the second housing portion 120 (e.g., in the regions of recesses 124 ) and a thumb on proximal surface of the pad 131 to press the first plunger portion 132 distally toward the skin of the user.
- the user can wrap four fingers of the user's hand around the housing assembly 110 of the injector device 100 , and can press the pad 131 of the first plunger portion 132 distally toward the skin of the user with the user's thumb.
- FIG. 25 A- 25 E are various views of the injector device 100 in a seventh configuration in which the needle 160 has been withdrawn and the injector device 100 has been separated from the user.
- FIGS. 25 A and 25 B are a back view and a front view, respectively, of the injector device 100 in the seventh configuration.
- FIG. 25 C is a cross-sectional view of the injector device 100 taken along line Y-Y of FIG. 25 B .
- FIG. 25 D is a side view of the injector deice 100 in the seventh configuration.
- FIG. 25 E is a cross-sectional view of the injector device 100 taken along line Z-Z of FIG. 25 D .
- the injector device 100 can be removed from the skin S of the user by proximally translating the injector device 100 relative to the skin S.
- the spring 156 can apply a force to the distal end wall of the needle sheath 150 such that the needle sheath 150 automatically extends to cover the portion of the needle 160 which has been withdrawn from the skin S.
- the needle sheath 150 can be fully extended to cover the needle 160 , including the sharp tip on the second end 163 of the needle 160 .
- accidental needle sticks may be reduced.
- the injector device 100 can be locked after injection and withdrawal such that the needle sheath 150 is restrained from being moved relative to the housing assembly 110 .
- the first housing portion 115 can be rotated relative to the second housing portion 120 such that the positional indicator notch 111 aligns with the closed indicator notch 121 .
- a portion of the first housing portion 115 e.g., a distal surface of the inwardly projecting retaining portions 114
- the injector device 100 can be disposed of via any suitable method.
- the cover 170 of the device may be comprised of an injection molded medical grade silicone.
- This silicone may have a relative density of Shore A hardness of about 60, or in the range of about 50 to 70 around the area where the needle is bonded and made sterile.
- the needle pull barb 180 of the injector may be molded in place, embedded in the cover. This needle pull barb 180 may comprise formed stainless steel wire or a Polythylene fiber that is co-molded, in place.
- the needle sheath 150 may be injection molded from a medical grade high-density polyethylene (HDPE).
- HDPE high-density polyethylene
- the return spring for the needle sheath 156 may be made from a tempered stainless steel with approximate diameter of 0.03′′, or about 0.01′′ to about 0.5′′, with 6 to 7 revolutions, or in a range of 3 to 10 revolutions, for example.
- the clear windows 122 may be molded from a clear ABS and the first and second housings, 120 and 115 , respectively, of the device may be injection molded from high strength ABS or a polycarbonate polymer, for example.
- the internal cartridge 190 of the device is to be injection molded from a colorless Cyclo-olefin Polymer (COP) Zeonex 420 or Zeonor 1020 R, or comprise a glass container.
- COP Cyclo-olefin Polymer
- the guide bushing 191 may be precision machined from brass or molded from a medical grade high-density polyethylene.
- the rubber seal for the injection needle 193 may be precision molded from a medical grade silicone.
- the needle catch feature 195 may be to be molded from a medical grade high density polyethylene or machined from a medical grade nylon.
- the outer second plunger portion 134 of the device may be injection molded from a colorless Cyclo-olefin Polymer (COP) Zeonex 420 or Zeonor 1020 R.
- the inner plunger 132 is to be injection molded with ABS.
- the rubber seal 140 is comprised of an injection molded medical grade silicone.
- the injection needle 160 is a precision rolled and machined stainless steel component.
- the injector device 100 can be included in a wearable injector assembly.
- the wearable injector assembly can include a casing 101 A.
- the casing 101 A can include a first casing portion 102 A and second casing portion 103 A.
- the casing 101 A can also include a seal 104 A.
- the injector device 100 can be inserted into the first casing portion 102 A.
- the second casing portion 103 A can be coupled to the first casing portion 102 A via any suitable coupling mechanism, such as via internal mating threads.
- the seal 104 A can be disposed between the first casing portion 102 A and the second casing portion 103 A such that the first casing portion 102 A and the second casing portion 103 A are sealingly coupled to protect the injector device 100 .
- the first casing portion 102 A can be coupled to a band 105 .
- the band 105 can be shaped and sized such that the band 105 can be worn on the wrist of a user as a bracelet.
- the band 105 can be shaped and sized to be worn on any suitable part of the user's body, such as an ankle.
- the band 105 can be shaped and sized to be coupled to a belt loop of a user's pants.
- the band 105 can include a fastening mechanism (e.g., hook and loop, a buckle) configured to couple a first portion of the band 105 to a second portion of the band such that the band 105 can be easily coupled to the user's body (e.g., a wrist).
- a fastening mechanism e.g., hook and loop, a buckle
- the injector device 100 can be included in a wearable injector assembly including an extended loop.
- the wearable injector assembly can include a casing 101 B.
- the casing 101 B can include a first casing portion 102 B and second casing portion 103 B.
- the casing 101 B can also include a seal 104 B.
- the injector device 100 can be inserted into the first casing portion 102 B.
- the second casing portion 103 B can be coupled to the first casing portion 102 B via any suitable coupling mechanism, such as via internal mating threads.
- the seal 104 B can be disposed between the first casing portion 102 B and the second casing portion 103 B such that the first casing portion 102 B and the second casing portion 103 B are sealingly coupled to protect the injector device 100 .
- the first casing portion 102 B can be coupled to a loop 106 .
- the loop 106 can be shaped and sized such that the loop 106 and the casing 101 B (containing the injector device 100 ) can be worn as a necklace.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Environmental & Geological Engineering (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Devices and methods for a compact injector are provided with a compact configuration for ease of carrying or storage, and an activated configuration ready for injection. In the compact configuration, a plunger and a needle are both retracted into the injector housing, and upon actuation to the activated configuration, the plunger extends proximally and the needle extends distally, ready for injection. An extendable needle shield is also provided to block visibility of the needle during injection, and to reduce the risk of inadvertent needle stick at other times, including disposal.
Description
- This application is a continuation of U.S. patent application Ser. No. 16/961,636 filed Jul. 10, 2020, issued as U.S. Pat. No. 11,607,502 on Mar. 21, 2023, which is a national stage entry of International Patent Application PCT/US2019/013017 filed on Jan. 10, 2019, which in turn claims priority to U.S. Provisional Application No. 62/615,924 filed Jan. 10, 2018, and U.S. Provisional Application No. 62/621,506 filed Jan. 24, 2018, which are incorporated herein by reference, in their entirety, for any purpose.
- Embodiments described herein relate to compact injector systems, apparatus, and methods. According to a 2015 survey conducted by the National Institute of Health, 1.6-5.1% of American adults are at risk for anaphylaxis, or roughly 4-12.75 million (Altman, Ashley M., et al. “Anaphylaxis in America: A national physician survey.” The Journal of Allergy and Clinical Immunology, U.S. National Library of Medicine, March 2015). This does not include the 4 to 6% of American children at risk, a percentage that is on the rise (Sifferlin, Alexandra. “What food allergies are costing families—and the economy.” CNN, Cable News Network, 21 Mar. 2014). Allergenic triggers vary, but of the population of Americans at risk for anaphylaxis: 34% are allergic to medications like penicillin and non-steroid anti-inflammatories, 31% are allergic to foods—most commonly peanuts, tree nuts, dairy, soy, eggs, and shellfish, and 20% of those at risk for anaphylaxis are allergic to bees or other insect stings (“Anaphylaxis in America AAAAI.” The American Academy of Allergy, Asthma & Immunology, 15 Oct. 2013). The average person with a life-threatening allergic reaction has ninety seconds to be delivered a life-saving dose of epinephrine before the throat closes and suffocation begins (anaphylaxis). Less commonly, the reaction can be delayed for several hours before rapid onset of symptoms and throat closure. Risk of death increases when patients are not carrying their EPIPEN® or are unable to communicate where the EPIPEN® is before throat closure. From 1999-2009 (latest available data), mortality rates ranged from 186-225 deaths per year (“Facts and Statistics—Food Allergy Research & Education.” Facts and Statistics—Food Allergy Research & Education. https://www.foodallergy.org/life-food-allergies/food-allergy-101/facts-and-statistics, 22 Mar. 2017).
- Currently, as a first line of treatment for extreme allergic reactions, patients are often prescribed an EPIPEN® two-pack: auto-injection devices to be carried at all times and renewed each year. Although EPIPENS® dominate the market, they are unwieldy. When encased, they are each six inches long and over an inch wide. As a result, it is estimated that two-thirds of EPIPEN® users do not carry them on their person (“Sanofi Announces Auvi-Q™, the First and Only Voice-Guided Epinephrine Auto-Injector, is Now Available in the U.S.” Sanofi. 28 Jan. 2013). Further, the EPIPEN® is intended to be exclusively administered in the upper thigh, and the spring inside an EPIPEN® delivers twenty pounds of force to ensure the needle can get through jeans. They are very painful and incite fear of use.
- Systems, apparatus, and methods for compact injection are described herein. Devices and methods may comprise a compact injector with a compact configuration for ease of carrying or storage, and an activated configuration ready for injection. In some examples, the compact configuration may be approximately the size of a lip balm stick, such as a CHAPSTICK®, with a diameter of less than 20 mm and a length of less than 90 mm, 80 mm, or 70 mm, for example, though other diameters and lengths, including larger device, are also contemplated. In the compact configuration, a plunger and a needle are both retracted into the injector housing, and upon actuation to the activated configuration, the plunger extends proximally and the needle extends distally, ready for injection. An extendable needle shield is also provided to block visibility of the needle during injection, and to reduce the risk of inadvertent needle stick at other times, including disposal.
- In one exemplary embodiment, an apparatus is provided, comprising a housing assembly, including a first housing portion and a second housing portion, the first housing portion and the second housing portion collectively defining a first interior cavity, an internal cartridge defining a reservoir, the internal cartridge at least partially disposed within the interior cavity, and a plunger assembly which includes a first plunger portion, a second plunger portion, and a sealing element, the second plunger portion defining a distal end wall, a sidewall, and a second interior cavity, the first plunger portion movably disposed within the second interior cavity, the second plunger portion slidably disposed within the reservoir of the internal cartridge, the sealing element coupled to the second plunger portion proximal of the distal end wall of the second plunger portion, the sealing element configured to sealingly couple the second plunger portion to the internal cartridge such that the reservoir is partially defined by the sealing element, wherein the first housing portion is configured to be rotated relative to the second housing portion between a first position and a second position, the first plunger portion prevented from being longitudinally translated relative to the second plunger portion when the first housing portion is in the first position, the first plunger portion longitudinally translatable relative to the second plunger portion when the first housing portion is in the second position. wherein the first housing portion may further comprise a slot in the proximal end of the first housing portion and a retaining tab extending into the slot and the first plunger portion includes a latch, the latch being disposed within the slot and engaged with the retaining tab when the first housing portion is in the first position, the latch being disengaged from the retaining tab and translatable through the slot when the first housing portion is in the second position. In some further variations, when the first housing portion is in the first position, the second plunger portion may be disposed within the reservoir such that a circumferential gap is defined between the sidewall of the second plunger portion and an inner surface of the internal cartridge and such that a space is defined between the distal end wall and a distal end of the internal cartridge, the circumferential gap being in fluid communication with the space. The second plunger portion may comprise a guide extending from the sidewall, the guide disposed between the distal end wall of the second plunger portion and the sealing element, the guide contacting an inner surface of the internal cartridge. The first plunger portion may further comprise at least one tab biased to expand axially from a first compressed configuration to a second projecting configuration relative to a central longitudinal axis of the first plunger portion when the first housing portion is in the second position and the first plunger portion has been longitudinally translated proximally relative to the first housing portion, and at least one tab may be configured to extend through a recess of the second plunger portion in the second projecting configuration. The apparatus may further comprise a needle and a needle sheath, the needle partially disposed within the reservoir, the needle sheath partially disposed within the first interior cavity, the needle sheath prevented from being longitudinally translated relative to the second housing portion when the first housing portion is in the first position, the needle sheath longitudinally translatable relative to the second housing portion when the first housing portion is in the second position. The needle sheath may include a projecting portion, the projecting portion engaged with a retaining surface of the second housing portion when the first housing portion is in the first position, and the projecting portion disengaged from the retaining surface of the second housing portion when the first housing portion is in the second position. The apparatus may also further comprise a spring having a first end and a second end, the first end of the spring coupled to the internal cartridge and a second end of the internal cartridge coupled to the needle sheath such that the needle sheath is biased toward an expanded position relative to the internal cartridge. The apparatus may also further comprise a needle cover, the needle sheath including a proximal end and a distal end, the needle including a proximal end and a distal end, the proximal end of the needle being disposed within the reservoir, the distal end of the needle and the distal end of the needle sheath coupled to the needle cover.
- The needle may comprise a hole proximate the distal end of the needle, the needle cover being coupled to the needle via a wire threaded through the hole. The apparatus may further comprise a catch disposed within the internal cartridge, the needle including an engagement portion, the engagement portion configured to engage with the catch upon distal translation of the needle relative to the internal cartridge. A distance from a distalmost portion of the needle cover to a proximalmost portion of the plunger may be less than about 90 mm when the first housing portion is in the first position, the first plunger portion is partially disposed within the second cavity, and the needle cover is coupled to the distal end of the needle sheath. The second plunger portion may comprise a proximal end, the sealing element being disposed proximate the proximal end of the second plunger portion.
- In another embodiment, a method is provided, comprising rotating a first housing portion relative to a second housing portion such that a latch of a plunger is disengaged from a retaining tab of the second housing portion, an internal cartridge defining a reservoir at least partially disposed within a first interior cavity collectively defined by the first housing portion and the second housing portion, the plunger including a first plunger portion and a second plunger portion, the second plunger portion defining a second interior cavity, the first plunger portion movably disposed within the second interior cavity, the second plunger portion slidably disposed within the reservoir of the internal cartridge, proximally translating the first plunger portion relative to the second plunger portion and relative to the first housing portion such that at least one tab of the first plunger portion transitions from a first, compressed configuration to a second, projecting configuration, and distally translating the first plunger portion such that the at least one tab distally translates the second plunger portion within the internal cartridge. The rotating of the first housing portion relative to the second housing portion may be configured to cause a needle sheath to rotate from an engaged position to a disengaged position relative to the second housing portion and to distally translate relative to the second housing portion such that a needle cover coupled to a distal end of the needle sheath and coupled to a distal end of a needle disposed within the needle sheath distally translates the needle relative to the internal cartridge. The method may further comprise removing the needle cap such that the needle is further distally translated relative to the internal cartridge.
- In still another embodiment, an apparatus is provided, comprising a housing assembly including a first housing portion and a second housing portion, the first housing portion and the second housing portion collectively defining a first interior cavity, an internal cartridge defining a reservoir, the internal cartridge at least partially disposed within the first interior cavity, the internal cartridge including a catch, a plunger assembly slidably disposed within the reservoir of the internal cartridge, a needle sheath including a proximal end and a distal end, the proximal end of the needle sheath disposed within the first interior cavity, a needle including a proximal end and a distal end, the proximal end of the needle disposed within the reservoir, the needle including an engagement portion disposed within the reservoir, and a needle cover coupled to the distal end of the needle sheath and the distal end of the needle, the first housing portion configured to be rotated relative to the second housing portion between a first position and a second position, the needle sheath prevented from being longitudinally translated relative to the second housing portion when the first housing portion is in the first position, the needle sheath longitudinally translatable relative to the second housing portion when the first housing portion is in the second position, the needle cover, the needle, and the needle sheath being arranged such that distal translation of the needle sheath relative to the housing translates the needle distally via the needle cover such that the engagement portion of the needle engages with the catch feature of the internal cartridge. The apparatus may be configured such that removal of the needle cover from the needle and the needle sheath distally translates the engagement portion of the needle relative to the catch feature of the internal cartridge. The apparatus may further comprise a seal, the plunger assembly including a distal end wall and a sidewall, the seal coupled to the sidewall of the plunger assembly proximal of the distal end wall of the plunger assembly, the seal in sealing contact with the internal cartridge such that the seal partial defines the reservoir. The plunger assembly may comprise a guide extending from the sidewall of the plunger assembly to the internal cartridge, the guide disposed on the sidewall of the plunger assembly between the seal and the distal end wall of the plunger assembly.
- In another embodiment, a method of preparing an injector is provided, comprising removing an injector cap from an injector housing, pulling a needle out of a medicament cartridge located in the injector housing, twisting the injector housing to unlock an extendible plunger, and extending a needle sheath from the injector housing. The removal of the injector cap and the pulling of the needle may occur simultaneously. The pulling of the needle may be performed using a needle wire through a side hole of the needle, and wherein the needle wire is attached to the injector cap.
- In another embodiment, an injection subassembly is provided, comprising a needle guide bushing, comprising a proximal end, a distal end with a needle catch interface, and a lumen therebetween, and a needle slidably located within the needle guide bushing, comprising a proximal end with a bushing catch interface complementary to the needle catch interface, a beveled distal end with a transverse opening, and longitudinal lumen between the proximal end and the distal end. The injection subassembly may further comprise a medicament cartridge, comprising a proximal end, a distal end and an internal cavity therebetween, and wherein the needle guide bushing resides within the internal cavity of the medicament cartridge and the distal end of the needle is located distal to the distal end of the medicament cartridge. The injection subassembly may further comprise a slidable stop within the internal cavity. The slidable seal may comprise a proximal surface accessible from the proximal end of the medicament cartridge, the proximal surface comprising a plunger interlocking interface. The plunger interface may be a helical screw interface. The injection subassembly may further comprise a syringe connector. The syringe connector may comprise a proximal friction interfit interface or a Luer connector. The syringe connector and the needle guide bushing may be integrally formed. The needle guide bushing may reside within the syringe connector. The bushing catch interface of the needle may comprise distally tapered barbs, and the needle catch interface of the needle guide bushing may comprise distally tapered internal ridges complemental to the distally tapered barbs.
- In another example, a method of injecting a therapeutic agent is provided, comprising removing an injector cap from an injector housing, pulling a needle out of a medicament cartridge located in the injector housing, twisting the injector housing to unlock an extendible plunger, extending a needle sheath from the injector housing, inserting the needle into an injection site, and depressing the plunger to deliver a therapeutic agent contained in the medicament cartridge. The removal of the injector cap and the pulling of the needle may occur simultaneously. The pulling of the needle may be performed using a needle wire through a side hole of the needle, and wherein the needle wire is attached to the injector cap.
- Although certain examples described herein are for intramuscular injection of epinephrine for treatment or prevention of anaphylactic shock, the injectors described herein may also be provided for use with any of a variety of clinical indications, therapeutic agents, and/or injection routes, and is not limited to ambulatory or emergency uses. For example, the injector may also be used for intravenous or subcutaneous injection, or may comprise a Luer lock in place of a needle for connection to a peripheral or central venous line. The injector may be configured with a variety of therapeutic or diagnostic agents, including but not limited to agents for use in radiologic imaging, advanced cardiac life support, psychiatric settings, home antibiotic treatment for a variety of infection disease indications, etc. Examples of particular agents include but are not limited to haloperidol, chlorpromazine, lorazepam, morphine, codeine, adenosine, amiodarone, atropine, dopamine, lidocaine, magnesium, calcium chloride, procainamide, ACE inhibitors (e.g. enalapril), beta blockers (e.g. metoprolol, atenolol, propranolol, esmolol, labetalol, sotalol), DIGIBIND®, digoxin, dobutamine, fibrinolytic agents (e.g. alteplase, anistreplase, reteplase, streptokinase, tPA), flecainide, furosemide, glucagon, heparin, mannitol, naloxone, nitroglycerin, nitroprusside, vasopressin, calcium channel blockers (e.g. verapamil), insulin and insulin analogues, or other diabetes agents, and the like.
-
FIGS. 1A-1C are various views of an injector device, according to an embodiment. -
FIG. 2 is an exploded view of the injector device ofFIG. 1A . -
FIGS. 3A-3G are various views of a cover of the injector device ofFIG. 1A in a first, attached configuration. -
FIGS. 3H-3N are various views of the cover ofFIGS. 3A-3G in a second, detached configuration. -
FIGS. 4A-4C are various views of a needle pull barb of the injector device ofFIG. 1A . -
FIGS. 5A-5C are various views of a needle of the injector device ofFIG. 1A coupled to the cover of the injector device via the needle pull barb of the injector device. -
FIGS. 6A-6E are various views of a needle sheath of the injector device ofFIG. 1A . -
FIGS. 7A-7F are various views of a housing assembly of the injector device ofFIG. 1A . -
FIGS. 8A-8F are various views of an internal cartridge of the injector device ofFIG. 1A . -
FIGS. 9A-9C are a front view, a top view, and a perspective view, respectively, of a guide bushing of the injector device ofFIG. 1A . -
FIGS. 10A-10C are a front view, a top view, and a perspective view, respectively, of a guide seal of the injector device ofFIG. 1A . -
FIGS. 11A-11D are various views of the catch feature of the injector device ofFIG. 1A . -
FIGS. 12A-12C are various views of the needle of the injector device ofFIG. 1A . -
FIGS. 13A-13C are various views of the internal cartridge, the needle, the guide bushing, the guide seal, and the catch feature of the injector device ofFIG. 1A in an injection configuration in which the needle is engaged with the catch feature. -
FIGS. 14A-14D are various views of a second plunger portion of a plunger assembly of the injector device ofFIG. 1A . -
FIGS. 15A-15C are various views of a sealing element of the injector device ofFIG. 1A . -
FIGS. 16A-16E are various views of a first housing portion of the injector device ofFIG. 1A . -
FIGS. 16F-16J are various views of the second housing portion of the injector device ofFIG. 1A . -
FIGS. 17A-17C are various views of the first plunger portion of the plunger assembly of the injector device ofFIG. 1A . -
FIGS. 18A-18G are various views of the injector device ofFIG. 1A in a first, locked configuration. -
FIGS. 19A-19G are various views of the injector device ofFIG. 1A in a second, unlocked configuration. -
FIGS. 20A-20G are various views of the injector device ofFIG. 1A in a third, uncovered configuration. -
FIGS. 21A-21G are various views of the injector device ofFIG. 1A in a fourth, extended or “ready” configuration. -
FIGS. 22A-22D are various views of the injector device ofFIG. 1A disposed on a skin of a user prior to penetration. -
FIGS. 23A-23D are various views of the injector device ofFIG. 1A in a fifth, penetration configuration. -
FIGS. 24A-24E are various views of the injector device ofFIG. 1A in a sixth, injection configuration. -
FIG. 25A-25E are various views of the injector device ofFIG. 1A in a seventh, withdrawn configuration. -
FIG. 26 is an exploded view of the injector device ofFIG. 1A included in a wearable injector assembly, according to an embodiment. -
FIG. 27 is an exploded view of the injector device ofFIG. 1A included in a wearable injector assembly, according to an embodiment. -
FIGS. 28A-28G are various views of an injector device cover, according to an embodiment. -
FIGS. 29A and 29B are distal and proximal perspective views, respectively, of the injector device cover ofFIGS. 28A-28G coupled to an injector device, according to an embodiment. -
FIGS. 30A-30E are various views of an injector device, according to an embodiment. -
FIGS. 31A and 31B are side elevational and longitudinal cross-sectional views, respectively of a separate needle hub assembly in a retracted configuration that may be used with a separate syringe.FIGS. 31C and 31D depict the needle hub assembly ofFIGS. 31A and 31B in an extended position, respectively.FIGS. 31E and 31F depict the needle hub assembly ofFIGS. 31A and 31B attached to a syringe, respectively. - The injection devices described herein are configured with a compact size so that the user can easily carry it or keep it close by, e.g. in a backpack, belt clip, bracelet or necklace, for example. When activated, the plunger can extend proximally and the needle can extend distally to facilitate injection of the medication. In some embodiments, the length of the device in the compact or storage configuration may be in the range of about 60 mm to about 70 mm, about 50 mm to about 80 mm, or about 62 mm to about 66 mm. The diameter may be in the range of about 18 mm to about 26 mm, about 16 mm to about 31 mm, or about 21 mm to about 25 mm. When the device is activated, the length may increase to be in a range of about 100 mm to about 110 mm, about 90 mm to about 120 mm, or about 103 mm to about 105 mm. Typically, the average diameter or largest axial cross-sectional dimension, will not change, but in other examples, the diameter may also change to a size in the range of about 5 mm to about 18 mm, about 9 mm to about 28 mm, or about 19 mm to about 26 mm. In the extended configuration, the plunger may extend an additional distance from the injector housing of about 0.1 mm to about 8 mm, about 0.1 mm to about 11 mm, or about 0.5 mm to about 7 mm, while the needle may extend an additional distance from the injector housing in the range about 0.5 mm to about 8 mm, about 0.1 mm to about 11 mm, or about 1 mm to about 7 mm.
-
FIGS. 1A-1C are various perspective views of aninjector device 100 shown in a locked configuration. As shown inFIGS. 1A-1C , theinjector device 100 includes ahousing assembly 110, aplunger assembly 130, aneedle sheath 150, and acover 170. Thehousing assembly 110 includes afirst housing portion 115 and asecond housing portion 120. Thefirst housing portion 115 is coupled to thesecond housing portion 120 such that thefirst housing portion 115 can be rotated relative to thesecond housing portion 120 to transition theinjector device 100 between the locked configuration shown inFIGS. 1A-1C and an unlocked configuration (shown, for example, inFIGS. 19A-19G ). As shown inFIGS. 1A-1C , thefirst housing portion 115 can include ribs disposed on the outer surface of thefirst housing portion 115 to facilitate gripping of thefirst housing portion 115 by the user. Although shown as including ribs, thefirst housing portion 115 can include any suitable shape, features, or materials to facilitate gripping, such as a textured surface. - The
first housing portion 115 can include apositional indicator notch 111. Thesecond housing portion 120 can include a lockedindicator notch 121 and anunlocked indicator notch 123. When theinjector device 100 is in the locked configuration, thepositional indicator notch 111 of thefirst housing portion 115 can be aligned with the lockedindicator notch 121 of thesecond housing portion 120, indicating to a user that theinjector device 100 is in the locked configuration. The rotation of thefirst housing portion 115 relative to thesecond housing portion 120 can rotate thepositional indicator notch 111 between alignment with the lockedindicator notch 121 and alignment with theunlocked indicator notch 123. Thus, the user can visually confirm that theinjector device 100 is in the locked and/or unlocked configuration. In some embodiments, the transition of thepositional indicator notch 111 into alignment with theunlocked indicator notch 123 can also include tactile or auditory feedback, such as a snap sound. - Additionally, the
first housing portion 115 can include a directional indicator 113 (e.g., an arrow), indicating the direction thefirst housing portion 115 can be rotated relative to thesecond housing portion 120 to transition theinjector device 100 between the locked configuration and the unlocked configuration. Thepositional indicator notch 111, the lockedindicator notch 121, theunlocked indicator notch 123, and thedirectional indicator 113 can be included on thehousing 110 via any suitable process or mechanism, such as by being molded with thehousing 110 or via attachment of, for example, adhesive markers. - Also as shown in
FIGS. 1A-1C , thesecond housing portion 120 can include one ormore windows 122. In some embodiments, thewindows 122 can provide visual access to the contents of a reservoir (e.g., thereservoir 192 described below) such that the user can verify that the contents (e.g., medicine) are suitable for injection (e.g., the user can verify that the contents are unexpired based on color). In some embodiments, thewindows 122 can provide visual access to an outer wall of theneedle sheath 150. The outer wall of theneedle sheath 150 can include a colored portion indicating a status of the injector device 100 (e.g., a green or red region indicating whether theinjector device 100 is ready for use and/or penetration). -
FIG. 2 is an exploded view of the components of theinjector device 100. As shown inFIG. 2 , theplunger assembly 130 includes afirst plunger portion 132 and asecond plunger portion 134. Theinjector device 100 also includes aneedle 160 and asealing element 140. Theinjector device 100 further includes aninternal cartridge 190 and aguide bushing 191, aguide seal 193, and acatch feature 195 disposed within theinternal cartridge 190. Aspring 156 can be disposed within theneedle sheath 150 and coupled to theinternal cartridge 190. Additionally, aneedle pull barb 180 can be engaged with thecover 170 and theneedle 160, as will be described below. -
FIGS. 3A-3G are various views of thecover 170 in a first, attached configuration. Specifically,FIG. 3A is a side view of thecover 170,FIG. 3B is a bottom view of thecover 170,FIG. 3C is a front view of thecover 170, andFIG. 3D is a top view of thecover 170.FIG. 3E is a cross-sectional view of thecover 170 taken along line A-A inFIG. 3C .FIG. 3F is a cross-sectional view of thecover 170 taken along line B-B inFIG. 3C .FIG. 3G is a perspective view of thecover 170. As shown, thecover 170 includes afirst tab 172A, asecond tab 172B, and astem 174. In the first, attached configuration (i.e., the configuration of thecover 170 when attached to the injector device 100), thefirst tab 172A and thesecond tab 172B are arranged such that thestem 174 extends between thefirst tab 172A and thesecond tab 172B. -
FIGS. 3H-3N are various views of thecover 170 in a second, detached configuration. Specifically,FIG. 3H is a side view of thecover 170,FIG. 3I is a bottom view of thecover 170,FIG. 3J is a front view of thecover 170, andFIG. 3K is a top view of thecover 170.FIG. 3L is a cross-sectional view of thecover 170 taken along line A-A inFIG. 3J .FIG. 3M is a cross-sectional view of thecover 170 taken along line B-B inFIG. 3J .FIG. 3N is a perspective view of thecover 170. In the second, detached configuration (i.e., the configuration of thecover 170 after being detached from the injector device 100), thefirst tab 172A and thesecond tab 172B are arranged such that thefirst tab 172A and thesecond tab 172B extend away from thestem 174. Thecover 170 can be transitioned from the first, attached configuration to the second, detached configuration via, for example, folding thefirst tab 172A and thesecond tab 172B relative to thestem 174. - The
cover 170 can be formed of any suitable material, such as molded rubber. In some further examples, a third or fourth tab may be provided, and/or the tabs may be longer and/or wider, to extend the full length of the injector, and may cover the proximal end of the injector, or entirely encapsulate the injector to provide additional safety and protection. For example,FIGS. 28A-28G are various views of acover 270. Specifically,FIGS. 28A and 28B are a proximal perspective view and a distal perspective view of thecover 270, respectively.FIGS. 28C, 28D , and 28E are a first side view, a front view, and a second side view (opposite the first side) of thecover 270, respectively.FIGS. 28F and 28G are a top or proximal view and a bottom or distal view of thecover 270, respectively. Thecover 270 can be similar in structure and/or function to thecover 170. For example, thecover 270 can include a base 278 including aninternal stem 274 having the same structure and/or function to theinternal stem 174 of thecover 170. Thecover 270 includes afirst tab 272A and asecond tab 272B. Thefirst tab 272A can optionally include anaccess flap 273A and thesecond tab 272B can optionally include anaccess flap 273B. Eachaccess flap first tab 272A andsecond tab 272B, respectively. Additionally, thefirst tab 272A can include anengagement flap 275A and thesecond tab 272B can include anengagement flap 275B. Theengagement flap 275A and theengagement flap 275B can be secured to each other via any suitable coupling mechanism. For example, as shown, theengagement flap 275A can include anengagement button 276A and define an engagement opening (not shown). Similarly, theengagement flap 275B can include anengagement button 276B and define an engagement opening (not shown). Theengagement button 276A can have a larger diameter than the engagement opening of theengagement flap 275B and theengagement button 276B can have a larger diameter than the engagement opening of theengagement flap 275A. Theengagement button 276A can be inserted through and retained in the engagement opening of theengagement flap 276B, and theengagement button 276B can be inserted through and retained in the engagement opening of theengagement flap 276A. Although not shown, in some embodiments, the engagement flaps 275A and 275B can be reversibly secured via a single engagement button on one of the engagement flaps 275A and 275B and a single engagement opening on the other of the engagement flaps 275A and 275B. -
FIGS. 29A and 29B are a front or distal perspective view and a back or proximal perspective view of aninjector device 200 including thecover 270. Theinjector device 200 can be similar in structure and/or function to any of the injector devices described herein, such asinjector device 100. For example, theinjector device 200 can include afirst plunger portion 232, afirst housing portion 215, asecond housing portion 220, and aneedle sheath 250, which can be the same or similar in structure and/or function to thefirst plunger portion 132, afirst housing portion 115, asecond housing portion 120, and aneedle sheath 150, respectively. As shown, thetabs base 278 of thecover 270, which is coupled to theneedle sheath 250, along the sides of thefirst housing portion 215 andsecond housing portion 220. The engagement flaps 275A and 275B can be secured to each other on the proximal side of thefirst plunger portion 232. While thecover 270 is attached to thefirst housing portion 215 and the second housing portion and secured on the proximal side of thefirst plunger portion 232, the access flaps 273A and 273B can be folded relative to thecover 270 such that windows on thesecond housing portion 220 can be viewed (e.g., to see the contents of an internal cartridge). In use, the engagement flaps 275A and 275B can be disengaged from each other and thetabs first housing portion 215 andsecond housing portion 220. The further use and deployment of theinjector device 200 can proceed the same or similarly as described with respect to theinjector device 100. -
FIGS. 4A-4C are various views of theneedle pull barb 180. Specifically,FIG. 4A is a perspective view of theneedle pull barb 180,FIG. 4B is a front view of theneedle pull barb 180, andFIG. 4C is a side view of theneedle pull barb 180. Theneedle pull barb 180 can have afirst end 182 and asecond end 184. Thefirst end 182 can be embedded in thecover 170 and thesecond end 184 can be coupled to theneedle 160, as will be described in more detail below. Theneedle pull barb 180 can be formed of any suitable material and can be, for example, a stainless steel single strand wire or filament. -
FIGS. 5A-5C are various views of theneedle 160 coupled to thecover 170 via theneedle pull barb 180. Specifically,FIG. 5A is a side view,FIG. 5B is a cross-sectional view taken along line A-A inFIG. 5A , andFIG. 5C is a perspective view of theneedle 160 coupled to thecover 170 via thepull barb 180. As shown inFIGS. 5A-5C , theneedle 160 can define alumen 162 and a hole 161 (as described below with respect toFIGS. 12A-12C ). Thefirst end 182 of theneedle pull barb 180 can be embedded in thecover 170 such that movement of thecover 170 can control movement of theneedle pull barb 180. Thesecond end 184 of theneedle pull barb 180 can be coupled to theneedle 160 such that when a first force is applied to thecover 170, thecover 170 can pull theneedle 160 in the direction of the first force. When a second force (such as a resistive force) is applied to theneedle 160, such as a second force opposite in direction from the first force, however, the first force (or a third force applied in the same direction as the first force) can detach thecover 170 from theneedle 160. For example, thesecond end 184 of theneedle pull barb 180 can be threaded through thelumen 162 of theneedle 160 and out of thehole 161. Thesecond end 184 can then be folded relative to theneedle 160 and/or embedded in thecover 170. Upon the application of sufficient force to thecover 170 relative to theneedle 160, thecover 170 can pull on thebarb 180 such that thebarb 180 breaks proximate the location of thehole 161 in theneedle 160. Thecover 170 can then be fully detached from theneedle 160, carrying the pieces of thebarb 180 away from theneedle 160. Although not shown, in some embodiments, rather than including a needle pull barb, thecover 170 can be formed of a material and sized such that thecover 170 can apply sufficient friction to theneedle 160 to translate theneedle 160, but can detach from theneedle 160 upon the application of a sufficient resistive or retaining force on theneedle 160 in the opposite direction of the movement of thecover 170. -
FIGS. 6A-6E are various views of theneedle sheath 150. Specifically,FIG. 6A is a front view of theneedle sheath 150,FIG. 6B is a side view of theneedle sheath 150,FIG. 6C is a bottom view of theneedle sheath 150, andFIG. 6E is a top view of theneedle sheath 150.FIG. 6D is a cross-sectional view of theneedle sheath 150 taken along line A-A inFIG. 6A . As shown, theneedle sheath 150 includes a first,proximal end 151 and a second,distal end 153. Theneedle sheath 150 includes abody 152 and projectingportions 154. For example, theneedle sheath 150 can include two projectingportions 154. - As described above with reference to
FIGS. 1A-1C , theneedle sheath 150 can include a number of indication regions 155 (e.g., one or two indication regions). Theindication regions 155 can be disposed on theneedle sheath 150 such that each indication region aligns with awindow 122 of thehousing assembly 110 when theinjector device 100 is fully assembled and in the locked configuration. In some embodiments, theindication regions 155 are transparent regions of the sidewall of theneedle sheath 150. Thus, when theinjector device 100 is in the locked configuration, the user can see through thewindows 122 of thehousing assembly 110 and through theindication regions 155 of theneedle sheath 150 into the reservoir 192 (shown inFIG. 8E ) of theinternal cartridge 190. The user can use this line of sight to verify the suitability of the contents of theinternal cartridge 190 for injection, such as by checking the color of the contents to verify the contents have not expired. In some embodiments, theindication regions 155 are colored regions of the sidewall that indicate a status of the device. For example, theindication regions 155 can be a first color, such as red, such that when theinjector device 100 is in the locked configuration, the user can see ared indication region 155 through eachwindow 122 of thehousing assembly 110, indicating that the device is locked and not ready for injection. In some embodiments, theneedle sheath 150 can include additional indicator regions or can be colored in regions outside of theindication regions 155 in a second color, such as green, such that when theneedle sheath 150 is extended relative to thehousing assembly 110, the user can see a green region through eachwindow 122 of thehousing assembly 110, indicating that the device is ready for operation. -
FIGS. 7A-7F are various views of thehousing assembly 110. Specifically,FIG. 7A is a front view of thehousing assembly 110,FIG. 7B is a side view of thehousing assembly 110,FIG. 7C is a top view of thehousing assembly 110,FIG. 7D is a side view opposite the side view ofFIG. 7B of thehousing assembly 110, andFIG. 7F is a bottom view of thehousing assembly 110.FIG. 7E is a cross-sectional view of thehousing assembly 110 taken along line A-A inFIG. 7A . As shown and described above, thehousing assembly 110 include thefirst housing portion 115 and thesecond housing portion 120. Thesecond housing portion 120 can be shaped to define tworecesses 124 in the outer surface of thesecond housing portion 120. As shown inFIG. 7E , thefirst housing portion 115 and thesecond housing portion 120 can collectively define aninterior cavity 116. Thefirst housing portion 115 and thesecond housing portion 120 can be coupled via any suitable coupling mechanism that allows for thefirst housing portion 115 to be rotated relative to thesecond housing portion 120. For example, although not shown, thefirst housing portion 115 and thesecond housing portion 120 can be coupled via a circlip or via an expandable spring within a groove of thefirst housing portion 115 or thesecond housing portion 120. - As shown in
FIG. 7C , twoslots 119 can be defined in a proximal end wall of the first housing portion 115 (also shown inFIG. 16B ). Additionally, thefirst housing portion 115 can include aretaining tab 118 extending into eachslot 119. - In some further embodiments, the
housing assembly 110 may further comprise hinged or fold-out finger handles at therecesses 124 to provide additional surface area to engage the user's fingers during injection. For example,FIGS. 30A-30E are various views of aninjector device 300. Theinjector device 300 can be the similar in structure and/or function to any of the injector devices described herein, such as theinjector device 100. For example, theinjector device 300 can include ahousing assembly 310 including afirst housing portion 315 and asecond housing portion 320, aneedle sheath 350, acover 370, aplunger assembly 330, aninternal cartridge 390, and aneedle 360, which can be the same or similar in structure and/or function to thehousing assembly 110 including afirst housing portion 115 and asecond housing portion 120, aneedle sheath 150, acover 170, aplunger assembly 130, aninternal cartridge 190, and aneedle 160, respectively. As shown, theinjector device 300 can include afirst finger handle 325A and asecond finger handle 325B coupled to thesecond housing portion 320. The first finger handle 325A and thesecond finger handle 325B can be rotated relative to thesecond housing portion 320 between an undeployed and a deployed configuration. In an undeployed configuration, the finger handles 325A and 325B can be disposed against thesecond housing portion 320 within therecesses 324 of thesecond housing portion 320. As shown, thefirst finger handle 325A can define anopening 326A and thesecond finger handle 325B can defined anopening 326B such that, in the undeployed configuration, thewindows 322 of thesecond housing portion 320 are not obstructed by the first finger handle 325A and thesecond finger handle 325B. In the deployed configuration, the finger handles 325A and 325B can project laterally from thehousing 320 such that a user's fingers can be placed into engagement with the distal side of the finger handles 325A and 325B during injection. In some embodiments, the finger handles 325A and 325B can be transitioned from the undeployed to the deployed configuration manually by a user. In some embodiments, each of the finger handles 325A and 325B can automatically transition from the undeployed to the deployed configuration via a spring (not shown). For example, in embodiments including a cover similar to thecover 270, the finger handles 325A and 325B can automatically deploy after the cover tabs are disengaged from the finger handles 325A and 325B. -
FIGS. 8A-8F are various views of theinternal cartridge 190. Specifically,FIG. 8A is a front view of theinternal cartridge 190,FIG. 8B is a side view of theinternal cartridge 190,FIG. 8C is a top view of theinternal cartridge 190,FIG. 8D is a side view opposite the side view ofFIG. 8B of theinternal cartridge 190, andFIG. 8F is a bottom view of theinternal cartridge 190.FIG. 8E is a cross-sectional view of theinternal cartridge 190 taken along line A-A inFIG. 8A . As shown, theinternal cartridge 190 includes a steppedoutlet 194 and one or more mating features 199. In this example, theinternal cartridge 190 can include three mating features 199 on each side of theinternal cartridge 190 such that theinternal cartridge 190 is configured to engage with thehousing assembly 110 via the mating features 199. Additionally, theinternal cartridge 190 can define areservoir 192 configured to hold medicament for injection by theinjector device 100. -
FIGS. 9A-9C are a front view, a top view, and a perspective view, respectively, of aguide bushing 191. Theguide bushing 191 can be shaped and sized to be disposed within theoutlet 194 of theinternal cartridge 190. Theguide bushing 191 can define alumen 186. The outer diameter of thelumen 186 can be similar to the outer diameter of theneedle 160 such that theguide bushing 191 can assist in directing theneedle 160 along a central longitudinal axis of theinjector device 100 as theneedle 160 is translated distally. In some examples, theguide bushing 191 may have a length in the range of about 6 mm to about 15 mm, or about 5 mm to about 18 mm. -
FIGS. 10A-10C are a front view, a top view, and a perspective view, respectively, of aguide seal 193. Theguide seal 193 defines acentral opening 193A and is shaped and sized to be disposed in theoutlet 194 of theinternal cartridge 190. Thecentral opening 193A of theguide seal 193 can be shaped and sized to provide a seal around theneedle 160 such that fluid in thereservoir 192 of theinternal cartridge 190 does not leak from theinternal cartridge 190 proximate theoutlet 194. Thus, theguide seal 193 can form a distal boundary of thereservoir 192. -
FIGS. 11A-11B are various views of thecatch feature 195. Specifically,FIG. 11A is a front view of thecatch feature 195,FIG. 11B is a top view of thecatch feature 195, and FIG. 11C is a perspective view of thecatch feature 195.FIG. 11D is a cross-sectional view taken along line A-A inFIG. 11A . As shown, thecatch feature 195 defines alumen 195A. The inner wall of thecatch feature 195 surrounding thelumen 195A includesbarbs 197. Thebarbs 197 can be shaped such that a distal-facing surface of eachbarb 197 is perpendicular to a central longitudinal axis of thecatch feature 195 running through thelumen 195A, and a proximal surface of eachbarb 197 is angled relative to the distal-facing surface. Thus, an engagement feature 168 (shown and described inFIGS. 12A-12C ) of theneedle 160 can be translated distally through thelumen 195A, but thebarbs 197 will prevent proximal movement of theengagement feature 168. Thecatch feature 195 can be formed of any suitable material and by any suitable process. For example, thecatch feature 195 can be molded or machined in high-density nylon. -
FIGS. 12A-12C are various views of theneedle 160. Specifically,FIG. 12A is a front view of theneedle 160,FIG. 12B is a side view of theneedle 160, andFIG. 12C is a cross-sectional view of theneedle 160 taken along line A-A inFIG. 12A . Theneedle 160 has afirst end 165, asecond end 163, and defines alumen 162 extending from thefirst end 165 to thesecond end 163. As shown inFIGS. 12A-12C , theneedle 160 can define a number ofinlets 164 in fluid communication with thelumen 162. Thesecond end 163 of theneedle 160 can include a needle tip and anoutlet 166. Additionally, as described above, theneedle 160 can define ahole 161 for engagement with theneedle pull barb 180. - Additionally, the
needle 160 can include anengagement feature 168 proximate thefirst end 165 of theneedle 160. Theengagement feature 168 can include a number of engagement portions shaped to engage with thebarbs 197 of thecatch feature 195 such that theneedle 160 can be moved distally relative to thecatch feature 195 but is prevented from moving proximally. -
FIGS. 13A-13C are various views of theinternal cartridge 190, theneedle 160, theguide bushing 191, theguide seal 193, and thecatch feature 195 in an injection configuration in which theengagement feature 168 of theneedle 160 is engaged with thecatch feature 195. Specifically,FIG. 13A is a front view,FIG. 13B is a cross-sectional view taken along line A-A ofFIG. 13A , andFIG. 13C is a top view. As shown inFIG. 13B , the distance from the proximal end of theinternal cartridge 190 to the distal end of theneedle 160 can be a length L1. Theneedle 160 can have a length L2. The injection depth of theneedle 160 relative to the skin (represented by line S) can be L3. In some embodiments, the length L1 can be, for example, about 3.22 inches. In some embodiments, the length L2 can be, for example, about 1.7 inches. In some embodiments, the length L3 can be, for example, about 0.9 inches. - As shown in
FIG. 13C , theinternal cartridge 190 can have an inner diameter D1 and an outer diameter D2. The inner diameter D1 can be, for example, about 0.355 inches. The outer diameter D2 can be, for example, about 0.434 inches. - In some embodiments, as shown in
FIGS. 31E to 31F , theneedle assembly 400 may be provided on aseparate needle hub 402 that is attachable to a separate syringe ormedicament cartridge 426. The separate syringe may be a standardized syringe or a customized syringe or cartridge. In these embodiments, theneedle hub 402 include one or moreinternal cavities attachment interface 408, such as a male Luer interface that is attachable to the distal end of a syringe. Any of a variety of other attachment interfaces may be used, including a female Luer or a friction fit, for example. In the embodiment depicted inFIGS. 31A to 31D , theneedle 410 slidably resides in aneedle lumen 412 and thecavity hub 402. Aneedle catch structure 414 is also provided with theneedle lumen 412 to receive the corresponding and complementary bushing orhub catch structure 416 that is located on theproximal end 418 of theneedle 410, as shown inFIGS. 31C and 31D . Theneedle 410 may also include a transverse orside opening 420 to receive a pull wire and cap as described elsewhere herein. As shown, theneedle lumen 412 and theneedle catch structure 414 are provided on abushing 422 located in thedistal cavity 404 of theassembly 400. Thebushing 422 is retained in thedistal cavity 404 by acap 424. Thecap 424 may be threadably attached to the rest of thehub 402, but in other examples may be welded or bonded to the hub, or attached by other mechanical interfaces. In still other examples, the needle lumen may be integrally formed with the hub and a bushing and/or cap is not used. In other examples, a guide bushing, a guide seal, and a catch feature maybe provided inside a single cavity of the needle hub, similar to the embodiments depicted inFIG. 2 . Theneedle hub assembly 400 may be provided as a separate product, optionally with a pull wire and cap, and/or outer housing components as described elsewhere herein, to a contract manufacturer of a prefilled syringe or medicament cartridge, as part of the manufacturing, assembly or packaging process of the device. Referring back toFIGS. 31E and 31F , theinternal cavity 428 of thesyringe 426 may be filled with the therapeutic agent prior to attachment of theneedle hub 402 and may include aslidable seal 430 that may be engaged or coupled to the distal end of a plunger rod (not shown) at anengagement structure 432 during use or during manufacture in order to dispense the therapeutic agent when theslidable seal 430 is displaced distally. -
FIGS. 14A-14D are various views of thesecond plunger portion 134 of theplunger assembly 130. Specifically,FIG. 14A is a front view of thesecond plunger portion 134. As shown inFIG. 14A , thesecond plunger portion 134 includes adistal end wall 139 and asidewall 138. Thesecond plunger portion 134 also includes a guidingfeature 136. The guidingfeature 136 can maintain the axial alignment of therubber seal 140, thefirst plunger portion 138 and/orsecond plunger portion 134 within theinternal cartridge 190 such that thesecond plunger portion 134 is disposed on and translates along a central axis of theinjection device 100. The guidingfeature 136 definesrecesses 136A such that fluid can flow from an area on a first side of the guidingfeature 136 to an area on a second side of the guidingfeature 136. The guiding feature may be located at the distal end of thesecond plunger portion 134 or proximal to the distal end of thesecond plunger portion 134, e.g. at a location 10%, 20%, 30%, 40%, or 50%, of the length of the length of thesecond plunger portion 134, relative to the distal end of theplunger portion 134, for example. Thesecond plunger portion 134 defines aseal recess 189 near the proximal end of thesecond plunger portion 134. Theseal recess 189 is shaped and sized to receive the sealingelement 140. Thesecond plunger portion 134 also defines four tab recesses 185 near the proximal end of thesecond plunger portion 134. -
FIG. 14B is a front view of thesecond plunger portion 134 in combination with the sealingelement 140.FIG. 14C is a cross-sectional view of thesecond plunger portion 134 in combination with the sealingelement 140 taken along line A-A inFIG. 14B .FIG. 14D is a top view of thesecond plunger portion 134 in combination with the sealingelement 140. As shown inFIG. 14C , thesecond plunger portion 134 includes aninternal compartment 187 defining aninterior cavity 198. Theinternal compartment 187 can be shaped and sized to receive the proximal end of theneedle 160 in the locked configuration of theinjector device 100. As shown, theinternal compartment 187 can be formed of a substantially cylindrical internal sidewall and a proximal end wall. Theinterior cavity 198 defined by theinternal compartment 187 can be in fluid communication with the interior of theinternal cartridge 190 and can thus form a boundary of thereservoir 192. As shown inFIG. 14D , thesecond plunger portion 134 can define fourguide recesses 188 on an inner surface of thesecond plunger portion 134. Atab recess 185 is disposed in eachguide recess 188. -
FIGS. 15A-15C are various views of the sealingelement 140. Specifically,FIG. 15A is a front view of the sealingelement 140,FIG. 15B is a top view of the sealingelement 140, andFIG. 15C is a perspective view of the sealingelement 140. The sealingelement 140 can be formed of any suitable material configured to provide a seal between thesecond plunger portion 132 and the internal wall of theinternal cartridge 190. -
FIGS. 16A-16E are various views of thefirst housing portion 115. Specifically,FIG. 16A is a front view of thefirst housing portion 115,FIG. 16B is a top view of thefirst housing portion 115,FIG. 16C is a bottom view of thefirst housing portion 115, andFIG. 16D is a perspective view of thefirst housing portion 115.FIG. 16E is a cross-sectional view of thefirst housing portion 115 taken along line A-A inFIG. 16A . As shown, thefirst housing portion 115 defines aproximal opening 112. Additionally, as shown inFIG. 16E , thefirst housing portion 115 includes two retainingportions 114 extending inward from an internal wall of thefirst housing portion 115. -
FIGS. 16F-16J are various views of thesecond housing portion 120. Specifically,FIG. 16F is a top view of thesecond housing portion 120,FIG. 16G is a perspective view of thesecond housing portion 120,FIG. 16H is a front view of thesecond housing portion 120, andFIG. 16I is a side view of thesecond housing portion 120.FIG. 16J is a cross-sectional view of thesecond housing portion 120 taken along line A-A inFIG. 16I . As shown, thesecond housing portion 120 includes twomating elements 129. Eachmating element 129 defines threerecesses 129A. Each of therecesses 129A is configured to align with and engage with amating feature 199 of theinternal cartridge 190 such that theinternal cartridge 190 and thesecond housing portion 120 are fixed relative to each other during operation of theinjector device 100. In some embodiments, theinternal cartridge 190 can be coupled to thesecond housing portion 120 via, for example, ultrasonic welding, solvent bonding, adhesive bonding, and the like -
FIGS. 17A-17C are various views of thefirst plunger portion 132. Specifically,FIG. 17A is a front view of thefirst plunger portion 132 andFIG. 17B is a side view of thefirst plunger portion 132.FIG. 17C is a cross-sectional view of thefirst plunger portion 132 taken along line A-A inFIG. 17A . Thefirst plunger portion 132 includes apad 131 and astem 135 extending distally from thepad 131. Thefirst plunger portion 132 also includes twolatches 133 extending distally from the distal surface of thepad 131. Additionally, thefirst plunger portion 132 includes fourtabs 137 projecting from a sidewall of thestem 135. Thetabs 137 can be biased outward from the sidewall of thestem 135 and/or from the central axis of thefirst plunger portion 132. Thetabs 137 can also be shaped and sized such that thetabs 137 can be disposed within the guide recesses 188 of thesecond plunger portion 134 when thefirst plunger portion 132 is disposed within thesecond plunger portion 134. Thetabs 137 can also be flexible such that when theinjector device 100 is in a locked configuration and thefirst plunger portion 132 is disposed within thesecond plunger portion 134, thetabs 137 are compressed by the inner sidewall of thefirst plunger portion 132. When thefirst plunger portion 134 is translated proximally relative to the second plunger portion 132 (e.g., when theinjector device 100 is in an unlocked configuration), thetabs 137 can translate within the guide recesses 188. Upon reaching the tab recesses 185, thetabs 137 can automatically transition from the compressed position to an expanded position in which thetabs 137 extend into or through the tab recesses 185. Thus, any distal translation of thefirst plunger portion 132 can apply a force to thesecond plunger portion 134 and translate thesecond plunger portion 134. Additionally, thefirst plunger portion 132 can include anindicator line 148 on thestem 135. Theindicator line 148 can be, for example, green in color. -
FIGS. 18A-18G are various views of theinjector device 100 in the first, locked configuration. Specifically,FIG. 18A is a front view of theinjector device 100 in the first, locked configuration.FIG. 18B is a cross-sectional view taken along line A-A ofFIG. 18A .FIG. 18C is a side view of theinjector device 100 in the first, locked configuration.FIG. 18D is a cross-sectional view taken along line B-B ofFIG. 18C .FIG. 18E is a top view of theinjector device 100 ofFIG. 18C .FIG. 18F is a cross-sectional view of theinjector device 100 taken along line G-G ofFIG. 18E .FIG. 18G is a cross-sectional view of theinjector device 100 taken along line H-H ofFIG. 18E . In some embodiments, the length of theinjector device 100 in the first, locked configuration (e.g., from the proximal surface of thefirst plunger portion 132 to the distal surface of the cover 170) can be equal to or less than about 3 inches. - As shown in
FIG. 18C and described above with reference toFIGS. 1A-1C , thepositional indicator notch 111 is aligned with theclosed indicator notch 121 when theinjector device 100 is in the first, locked configuration. Thereservoir 192 is defined by theguide seal 193, theinternal cartridge 190, the sealingelement 140, and thesecond plunger portion 134. As shown inFIG. 18B , thereservoir 192 can include acylindrical gap portion 141 between thesidewall 138 of thesecond plunger portion 134 and an inner surface of theinternal cartridge 190. Thereservoir 192 also includes theinterior cavity 198 defined by theinternal compartment 187 of thesecond plunger portion 134. Therecesses 188 of the guiding feature 136 (shown inFIG. 14D ), provide pathways for fluid transfer between thecylindrical gap portion 141 and the portion of thereservoir 192 distal of thedistal end wall 139 of thesecond plunger portion 134. Said another way, thecylindrical gap portion 141 is in fluid communication with a portion of thereservoir 192 distal of thesecond plunger portion 134. In the first, locked configuration of theinjection device 100, theneedle 160 is in an initial position relative to thecatch feature 195 such that thefirst end 165 of theneedle 160 is disposed within theinterior cavity 198 defined by theinternal compartment 187 of thesecond plunger portion 134. Thus, thefirst end 165 of theneedle 160 is disposed within thereservoir 192, with thelumen 162 of theneedle 160 in fluid communication with thereservoir 192, when theinjector device 100 is in the first, locked configuration. - Additionally, as can be seen in
FIG. 18B , although thespring 156 is compressed between the distal end wall of theneedle sheath 150 and the distal end wall of theinternal cartridge 190, the needle sheath is prevented from extending distally relative to thehousing assembly 110 due to the abutment between the projectingportions 154 of theneedle sheath 150 and the retainingportions 114 of thefirst housing portion 115. Additionally, the proximal retaining tab 118 (shown inFIG. 16B ) is engaged with thelatch 133 of thefirst plunger portion 132 such that thelatch 133, and thus thefirst plunger portion 132, is prevented from being translated proximally relative to thehousing assembly 110. -
FIGS. 19A-19G are various views of theinjector device 100 in the second, unlocked configuration. Specifically,FIG. 19A is a front view of theinjector device 100 in the second, unlocked configuration andFIG. 19B is a cross-sectional view of theinjector device 100 taken along line E-E ofFIG. 19A .FIG. 19C is a side view of theinjector device 100 in the second, unlocked configuration andFIG. 19D is a cross-sectional view of theinjector device 100 taken along line F-F ofFIG. 19C .FIG. 19E is a top view of theinjector device 100 ofFIG. 19C .FIG. 19F is a cross-sectional view of theinjector device 100 taken along line H-H ofFIG. 19E .FIG. 19G is a cross-sectional view of theinjector device 100 taken along line G-G ofFIG. 19E . - To transition the
injector device 100 from the first, locked configuration to the second, unlocked configuration, thefirst housing portion 115 can be rotated relative to thesecond housing portion 120. As shown inFIG. 19C and described above with reference toFIGS. 1A-1C , thepositional indicator notch 111 is aligned with theopen indicator notch 123 when theinjector device 100 is in the second, unlocked configuration. The rotation of thefirst housing portion 115 relative to thesecond housing portion 120 rotates the retainingportions 114 of thefirst housing portion 115 out of alignment with the projectingportions 154 of theneedle sheath 150. Thus, under the force of thespring 156, theneedle sheath 150 can be distally translated relative to thehousing assembly 110. Said another way, with the retainingportions 114 no longer obstructing the projectingportions 154 of thefirst housing portion 115 from distal movement relative to thehousing assembly 110, the projecting portions 154 (and thus, the entire needle sheath 150) can be translated distally by thespring 156. - The distal translation of the
needle sheath 150 by thespring 156 also distally translates thecover 170 coupled to the distal end of theneedle sheath 150. Due to thecover 170 being coupled to theneedle 160 via theneedle pull barb 180, the distal translation of thecover 170 by theneedle sheath 150 also distally translates theneedle 160 from the initial position relative to thecatch feature 195 to an intermediate position in which theengagement portion 168 of theneedle 160 is coupled to thecatch feature 195, as shown, for example, inFIG. 19B . In some embodiments, theengagement portion 168 of theneedle 160 can be in contact with thecatch feature 195 in the intermediate position. In some embodiments, theengagement portion 168 of theneedle 160 can be engaged with one ormore barbs 197 of thecatch feature 195 in the intermediate position. - Additionally, the rotation of the
first housing portion 115 relative to thesecond housing portion 120 rotates theslots 119 and proximal retainingtabs 118 of thefirst housing portion 115 relative to thelatching feature 133 of thefirst plunger portion 132. Thus, when theinjector device 100 is in the second, unlocked configuration, the latchingfeature 133 is aligned with theslots 119 of thefirst housing portion 115 and unobstructed from proximal translation by the proximal retainingtabs 118. -
FIGS. 20A-20G are various views of theinjector device 100 in a third, uncovered configuration. Specifically,FIG. 20A is a front view of theinjector device 100 in the third, uncovered configuration andFIG. 20B is a cross-sectional view of theinjector device 100 taken along line A-A inFIG. 20A .FIG. 20C is a side view of theinjector device 100 in the third, uncovered configuration andFIG. 20D is a cross-sectional view of theinjector device 100 taken along line L-L inFIG. 20C .FIG. 20E is a top view of theinjector device 100 ofFIG. 20C .FIG. 20F is a cross-sectional view of theinjector device 100 taken along line M-M inFIG. 20E .FIG. 20G is a cross-sectional view of theinjector device 100 taken along line N-N inFIG. 20E . - The
injector device 100 can be transitioned from the second, unlocked configuration to the third, uncovered configuration by removing thecover 170. As shown inFIG. 20A , for example, thecover 170 can be transitioned to the detached configuration by, for example, rotating the tabs 172 and pulling the tabs 172 distally in the direction of arrow Z-Z away from theneedle sheath 150. - Due to the coupling of the
cover 170 to the needlesecond end 163 of theneedle 160, the removal of thecover 170 from theneedle sheath 150 and thesecond end 163 of theneedle 160 translates theneedle 160 distally from the intermediate position to an engaged position in which theengagement feature 168 of theneedle 160 is fully engaged with thecatch feature 195. Specifically, theengagement feature 168 is engaged with thebarbs 197 of thecatch feature 195. As shown inFIG. 20B , for example, thefirst end 165 of theneedle 160 is disposed within thereservoir 192 such that thelumen 162 of theneedle 160 is in fluid communication with thereservoir 192 when theneedle 160 is in the engaged position and theinjector device 100 is in the third, uncovered configuration. -
FIGS. 21A-21G are various views of theinjector device 100 in a fourth, extended or “ready” configuration. Specifically,FIGS. 21A and 21B are a side view and a back view, respectively, of theinjector device 100 in the fourth, extended configuration.FIG. 21C is a top view of theinjector device 100 as shown inFIG. 21A .FIG. 21D is a cross-sectional view of theinjector device 100 taken along line A-A ofFIG. 21C .FIG. 21E is a cross-sectional view of theinjector device 100 taken along line L-L ofFIG. 21C .FIG. 21F is a cross-sectional view of theinjector device 100 taken along line N-N ofFIG. 21C .FIG. 21G is a cross-sectional view of theinjector device 100 taken along line M-M ofFIG. 21C . - To transition the
injector device 100 from the third, uncovered configuration to the fourth, extended configuration, thefirst plunger portion 132 can be proximally translated relative to thehousing assembly 110. As described above, the transition of thefirst housing portion 115 between the first, locked configuration and the second, locked configuration rotates the proximal retainingtabs 118 out of obstructing alignment with the latching features 133 of thefirst plunger portion 132. Thus, thefirst plunger portion 132 can be proximally translated (e.g., via pulling on the pad 131) relative to thesecond plunger portion 132 and thehousing assembly 110. As thefirst plunger portion 132 is proximally translated, thetabs 137 extending from thestem 135 of thefirst plunger portion 132 can slide within the guide recesses 188 of thesecond plunger portion 134 until thetabs 137 reach the tab recesses 185 of thesecond plunger portion 134. Upon reaching the tab recesses 185, thetabs 137 can transition from the compressed position to the expanded position, moving into or through the tab recesses 185. In such a configuration, theinjector device 100 is ready to be disposed on the skin of the user for the injection process. In some embodiments, visibility of theindicator line 148 on thestem 135 of thefirst plunger portion 132 proximal of thefirst housing portion 115 and/or an auditory and/or tactile snap can indicate that thefirst plunger portion 132 has been sufficiently proximally translated relative to thehousing assembly 110. Theindicator line 148 may be a green region with the same color as thewindow 122, to indicate when the device is ready for use. -
FIGS. 22A-22D are various views of theinjector device 100 disposed on a skin S (e.g., skin on the arm or the leg) of a user prior to penetration. Specifically,FIGS. 22A, 22B, and 22C are a front view, a back view, and a side view, respectively, of theinjector device 100 in the fourth, extended or ready configuration disposed on the skin S of a user.FIG. 22D is a cross-sectional view of theinjector device 100 taken along line T-T ofFIG. 22C . As shown, once thefirst plunger portion 132 has been withdrawn proximally relative to thehousing assembly 110 such that thetabs 137 are engaged with the tab recesses 185 of thesecond plunger portion 134, theinjector device 100 is ready for injection. Specifically, theinjector device 150 can be aligned with the skin S such that theneedle 160 is substantially perpendicular to the skin S. Thespring 156 within theneedle sheath 150 can maintain thedistal end 153 of theneedle sheath 150 against the skin S of the patient during the penetration and injection process. By providing a skin-facing surface area at thedistal end 153 of theneedle sheath 105, theneedle sheath 150 in combination with thespring 156 can also assist the user in aligning theneedle 160 with the skin S such that theneedle 160 is substantially perpendicular to the skin S. Furthermore, theneedle sheath 150 can obstruct the view of theneedle 160 by the user, reducing stress and/or anxiety associated with the sight of theneedle 160. -
FIGS. 23A-23D are various views of theinjector device 100 in a fifth configuration in which theneedle 160 has penetrated the skin S of the user. Specifically,FIG. 23A is a front view of theinjector device 100 in a penetration configuration.FIG. 23B is a cross-sectional view taken along line U-U ofFIG. 23A .FIG. 23C is a side view of theinjector device 100 in a penetration configuration.FIG. 23D is a cross-sectional view taken along line V-V ofFIG. 23C . - The
injector device 100 can be transitioned from the fourth, extended configuration to the fifth, penetration configuration by distally translating thehousing assembly 110 against the force of thespring 156 relative to the needle sheath 150 (i.e., toward the skin S). Due to theinternal cartridge 190 being fixedly coupled to thesecond housing portion 120 via the mating features 199, distal movement of thehousing assembly 110 distally translates theinternal cartridge 190. Additionally, due to the engagement between theengagement portion 168 of theneedle 160 and thebarbs 197 of thecatch feature 195, distal translation of theinternal cartridge 190 toward the skin S distally translates theneedle 160 through the skin S. -
FIGS. 24A-24E are various views of theinjector device 100 in a sixth configuration in which the medicament has been injected from thereservoir 192 into the user. Specifically,FIG. 24A is a back view of theinjector device 100 in the sixth configuration andFIG. 24B is a front view of theinjector device 100 in the sixth configuration.FIG. 24C is a cross-sectional view of theinjector device 100 taken along line W-W ofFIG. 24B .FIG. 24D is a side view of theinjector device 100 in the sixth configuration.FIG. 24E is a cross-sectional view of theinjector device 100 taken along line X-X ofFIG. 24D . - The
injector device 100 can be transitioned from the fifth, penetration configuration to the sixth, injection configuration by distally translating thefirst plunger portion 132 relative to thehousing assembly 110 such that thefirst plunger portion 132 distally translates thesecond plunger portion 134. The distal translation of thesecond plunger portion 134 can push fluid within thereservoir 192 into theinlets 164 of theneedle 160 such that the fluid flows through thelumen 162 of the needle, from theoutlet 166 of theneedle 160, and into the user (e.g., into the surrounding tissue). - The
first plunger portion 132 can be distally translated relative to thehousing assembly 110, for example, by the user pressing on thepad 131 of thefirst plunger portion 132 with a finger (e.g., a thumb). The user can use any suitable grip to hold the injector device during the penetration and injection process. In some embodiments, the user can place a finger in engagement on opposing sides of the second housing portion 120 (e.g., in the regions of recesses 124) and a thumb on proximal surface of thepad 131 to press thefirst plunger portion 132 distally toward the skin of the user. In some embodiments, the user can wrap four fingers of the user's hand around thehousing assembly 110 of theinjector device 100, and can press thepad 131 of thefirst plunger portion 132 distally toward the skin of the user with the user's thumb. -
FIG. 25A-25E are various views of theinjector device 100 in a seventh configuration in which theneedle 160 has been withdrawn and theinjector device 100 has been separated from the user. Specifically,FIGS. 25A and 25B are a back view and a front view, respectively, of theinjector device 100 in the seventh configuration.FIG. 25C is a cross-sectional view of theinjector device 100 taken along line Y-Y ofFIG. 25B .FIG. 25D is a side view of theinjector deice 100 in the seventh configuration.FIG. 25E is a cross-sectional view of theinjector device 100 taken along line Z-Z ofFIG. 25D . - As shown in
FIG. 25A , for example, after injection of the fluid in thereservoir 192 through theneedle 160, theinjector device 100 can be removed from the skin S of the user by proximally translating theinjector device 100 relative to the skin S. As theneedle 160 is withdrawn from the skin S, thespring 156 can apply a force to the distal end wall of theneedle sheath 150 such that theneedle sheath 150 automatically extends to cover the portion of theneedle 160 which has been withdrawn from the skin S. After theneedle 160 has been fully withdrawn from the skin S, theneedle sheath 150 can be fully extended to cover theneedle 160, including the sharp tip on thesecond end 163 of theneedle 160. Thus, accidental needle sticks may be reduced. In some embodiments, theinjector device 100 can be locked after injection and withdrawal such that theneedle sheath 150 is restrained from being moved relative to thehousing assembly 110. For example, thefirst housing portion 115 can be rotated relative to thesecond housing portion 120 such that thepositional indicator notch 111 aligns with theclosed indicator notch 121. In such a positon, a portion of the first housing portion 115 (e.g., a distal surface of the inwardly projecting retaining portions 114) can engage with and/or obstruct the needle sheath 150 (e.g., the outwardly projecting portion 154) from moving proximally relative to theneedle 160 and thehousing assembly 110. Theinjector device 100 can be disposed of via any suitable method. - The
cover 170 of the device may be comprised of an injection molded medical grade silicone. This silicone may have a relative density of Shore A hardness of about 60, or in the range of about 50 to 70 around the area where the needle is bonded and made sterile. Theneedle pull barb 180 of the injector may be molded in place, embedded in the cover. This needle pullbarb 180 may comprise formed stainless steel wire or a Polythylene fiber that is co-molded, in place. Theneedle sheath 150 may be injection molded from a medical grade high-density polyethylene (HDPE). The return spring for theneedle sheath 156 may be made from a tempered stainless steel with approximate diameter of 0.03″, or about 0.01″ to about 0.5″, with 6 to 7 revolutions, or in a range of 3 to 10 revolutions, for example. Theclear windows 122 may be molded from a clear ABS and the first and second housings, 120 and 115, respectively, of the device may be injection molded from high strength ABS or a polycarbonate polymer, for example. Theinternal cartridge 190 of the device is to be injection molded from a colorless Cyclo-olefin Polymer (COP)Zeonex 420 or Zeonor 1020R, or comprise a glass container. Theguide bushing 191 may be precision machined from brass or molded from a medical grade high-density polyethylene. The rubber seal for theinjection needle 193 may be precision molded from a medical grade silicone. Theneedle catch feature 195 may be to be molded from a medical grade high density polyethylene or machined from a medical grade nylon. The outersecond plunger portion 134 of the device may be injection molded from a colorless Cyclo-olefin Polymer (COP)Zeonex 420 or Zeonor 1020R. Theinner plunger 132 is to be injection molded with ABS. Therubber seal 140 is comprised of an injection molded medical grade silicone. Theinjection needle 160 is a precision rolled and machined stainless steel component. - As shown in
FIG. 26 , theinjector device 100 can be included in a wearable injector assembly. The wearable injector assembly can include acasing 101A. Thecasing 101A can include afirst casing portion 102A andsecond casing portion 103A. Thecasing 101A can also include aseal 104A. Theinjector device 100 can be inserted into thefirst casing portion 102A. Thesecond casing portion 103A can be coupled to thefirst casing portion 102A via any suitable coupling mechanism, such as via internal mating threads. Theseal 104A can be disposed between thefirst casing portion 102A and thesecond casing portion 103A such that thefirst casing portion 102A and thesecond casing portion 103A are sealingly coupled to protect theinjector device 100. As shown, thefirst casing portion 102A can be coupled to aband 105. Theband 105 can be shaped and sized such that theband 105 can be worn on the wrist of a user as a bracelet. Alternatively, theband 105 can be shaped and sized to be worn on any suitable part of the user's body, such as an ankle. In some embodiments, theband 105 can be shaped and sized to be coupled to a belt loop of a user's pants. Although not shown, theband 105 can include a fastening mechanism (e.g., hook and loop, a buckle) configured to couple a first portion of theband 105 to a second portion of the band such that theband 105 can be easily coupled to the user's body (e.g., a wrist). - As shown in
FIG. 27 , theinjector device 100 can be included in a wearable injector assembly including an extended loop. The wearable injector assembly can include acasing 101B. Thecasing 101B can include afirst casing portion 102B andsecond casing portion 103B. Thecasing 101B can also include aseal 104B. Theinjector device 100 can be inserted into thefirst casing portion 102B. Thesecond casing portion 103B can be coupled to thefirst casing portion 102B via any suitable coupling mechanism, such as via internal mating threads. Theseal 104B can be disposed between thefirst casing portion 102B and thesecond casing portion 103B such that thefirst casing portion 102B and thesecond casing portion 103B are sealingly coupled to protect theinjector device 100. As shown, thefirst casing portion 102B can be coupled to aloop 106. Theloop 106 can be shaped and sized such that theloop 106 and thecasing 101B (containing the injector device 100) can be worn as a necklace. - While various embodiments have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods described above indicate certain events occurring in certain order, the ordering of certain events may be modified. Additionally, some of the events may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above.
- Where schematics and/or embodiments described above indicate certain components arranged in certain orientations or positions, the arrangement of components may be modified. While the embodiments have been particularly shown and described, it will be understood that various changes in form and details may be made. Any portion of the apparatus and/or methods described herein may be combined in any combination, except mutually exclusive combinations. The embodiments described herein can include various combinations and/or sub-combinations of the functions, components, and/or features of the different embodiments described.
Claims (1)
1. A medical device as described herein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/186,502 US20240091461A1 (en) | 2018-01-10 | 2023-03-20 | Compact injector systems and methods |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862615924P | 2018-01-10 | 2018-01-10 | |
US201862621506P | 2018-01-24 | 2018-01-24 | |
PCT/US2019/013017 WO2019140067A1 (en) | 2018-01-10 | 2019-01-10 | Compact injector systems and methods |
US202016961636A | 2020-07-10 | 2020-07-10 | |
US18/186,502 US20240091461A1 (en) | 2018-01-10 | 2023-03-20 | Compact injector systems and methods |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/961,636 Continuation US11607502B2 (en) | 2018-01-10 | 2019-01-10 | Compact injector systems and methods |
PCT/US2019/013017 Continuation WO2019140067A1 (en) | 2018-01-10 | 2019-01-10 | Compact injector systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20240091461A1 true US20240091461A1 (en) | 2024-03-21 |
Family
ID=67218771
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/961,636 Active US11607502B2 (en) | 2018-01-10 | 2019-01-10 | Compact injector systems and methods |
US18/186,502 Pending US20240091461A1 (en) | 2018-01-10 | 2023-03-20 | Compact injector systems and methods |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/961,636 Active US11607502B2 (en) | 2018-01-10 | 2019-01-10 | Compact injector systems and methods |
Country Status (8)
Country | Link |
---|---|
US (2) | US11607502B2 (en) |
EP (1) | EP3737443A4 (en) |
JP (1) | JP7304354B2 (en) |
CN (1) | CN111836658B (en) |
AU (1) | AU2019206534A1 (en) |
CA (1) | CA3088158A1 (en) |
MX (1) | MX2020007385A (en) |
WO (1) | WO2019140067A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11675592B2 (en) | 2021-06-17 | 2023-06-13 | International Business Machines Corporation | Instruction to query for model-dependent information |
US11693692B2 (en) | 2021-06-17 | 2023-07-04 | International Business Machines Corporation | Program event recording storage alteration processing for a neural network accelerator instruction |
US11734013B2 (en) | 2021-06-17 | 2023-08-22 | International Business Machines Corporation | Exception summary for invalid values detected during instruction execution |
US11797270B2 (en) | 2021-06-17 | 2023-10-24 | International Business Machines Corporation | Single function to perform multiple operations with distinct operation parameter validation |
US11269632B1 (en) | 2021-06-17 | 2022-03-08 | International Business Machines Corporation | Data conversion to/from selected data type with implied rounding mode |
US11669331B2 (en) | 2021-06-17 | 2023-06-06 | International Business Machines Corporation | Neural network processing assist instruction |
USD1022202S1 (en) * | 2022-01-27 | 2024-04-09 | Hangzhou Wormhole Import and Export Trading Co., Ltd. | Wireless power supply tattoo pen |
USD1019948S1 (en) * | 2022-01-27 | 2024-03-26 | Hangzhou Wormhole Import and Export Trading Co., Ltd. | Wireless power supply tattoo pen |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7357790B2 (en) * | 2003-12-18 | 2008-04-15 | Tecpharma Licensing Ag | Auto-injector with active agent container latching |
US20130082057A1 (en) * | 2011-09-30 | 2013-04-04 | Becton Dickinson France, S.A.S. | Syringe Assembly Having a Telescoping Plunger Rod |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1436707A (en) | 1921-08-10 | 1922-11-28 | American Platinum Works | Adjustable and safety regulating device for hypodermic needles |
US2833280A (en) | 1952-12-19 | 1958-05-06 | Jr George N Hein | Syringe assembly |
US3043304A (en) | 1959-03-30 | 1962-07-10 | Brunswick Corp | Hypodermic needle mount |
US3534734A (en) | 1969-04-10 | 1970-10-20 | Joseph J Budreck | Disposable hypodermic syringe |
US3605744A (en) | 1969-04-22 | 1971-09-20 | Edward M Dwyer | Injection apparatus and method of injecting |
US3783997A (en) | 1972-04-17 | 1974-01-08 | Sherwood Medical Ind Inc | Syringe package |
US3841329A (en) | 1972-09-11 | 1974-10-15 | Upjohn Co | Compact syringe |
US3820652A (en) | 1972-11-14 | 1974-06-28 | T Thackston | Packaged syringe construction |
DE2315367A1 (en) | 1973-03-28 | 1974-10-17 | Hoechst Ag | SINGLE USE INJECTION SYRINGE |
US4011868A (en) | 1975-05-19 | 1977-03-15 | Friend John H | Hypodermic syringe with articulate plunger |
US4221218A (en) | 1979-01-18 | 1980-09-09 | Pfleger Frederick W | Disposable hypodermic syringe |
US4493704A (en) | 1982-11-29 | 1985-01-15 | Oximetrix, Inc. | Portable fluid infusion apparatus |
US4583973A (en) | 1984-04-11 | 1986-04-22 | Robert Humphrey | Viscous fluid timed infusion device |
US4581023A (en) | 1985-02-12 | 1986-04-08 | Kuntz David H | Hypodermic syringe assembly |
US4601708A (en) | 1985-09-09 | 1986-07-22 | Pavel Jordan | Automatic injection for syringe needle, and assembly |
US4710171A (en) | 1986-06-09 | 1987-12-01 | The Kendall Company | Needle depth setting sheath assembly and needle stop |
US4863433A (en) | 1988-05-23 | 1989-09-05 | Diamond Scientific Co. | Syringe |
FR2638359A1 (en) | 1988-11-03 | 1990-05-04 | Tino Dalto | SYRINGE GUIDE WITH ADJUSTMENT OF DEPTH DEPTH OF NEEDLE IN SKIN |
US5048684A (en) | 1990-02-01 | 1991-09-17 | Becton, Dickinson And Company | Compact syringe and catheter package |
US5876380A (en) | 1994-10-19 | 1999-03-02 | Manganini; Steven J. | Portable syringe dispenser system |
SE9502285D0 (en) | 1995-06-22 | 1995-06-22 | Pharmacia Ab | Improvements related to injections |
HU227056B1 (en) | 2001-11-09 | 2010-06-28 | Alza Corp | Collapsible syringe cartridge related cases |
WO2004004811A1 (en) | 2002-07-02 | 2004-01-15 | Terumo Kabushiki Kaisha | Syringe and prefilled syringe |
JP4010900B2 (en) | 2002-07-26 | 2007-11-21 | テルモ株式会社 | Syringe |
EP1816995A4 (en) | 2004-12-03 | 2009-11-11 | Duoject Inc | Cartridge, device and method for pharmaceutical storage, mixing and delivery |
NZ554828A (en) | 2004-12-06 | 2010-07-30 | Washington Biotech Corp | Medicine injection devices and methods |
US7972312B2 (en) | 2005-04-11 | 2011-07-05 | Koopman Robert A | Compac syringe |
US20060276747A1 (en) | 2005-06-06 | 2006-12-07 | Sherwood Services Ag | Needle assembly with removable depth stop |
US20070005075A1 (en) | 2005-06-17 | 2007-01-04 | Bogert Roy B | Telescoping plunger assembly |
EP1754499A1 (en) | 2005-08-19 | 2007-02-21 | Wei-Shui Wu | Safety hypodermic syringe with retractable needle carrier |
US7462169B2 (en) | 2007-01-23 | 2008-12-09 | Becton, Dickinson And Company | Safety shield system for an injection pen needle |
US20080221529A1 (en) | 2007-03-05 | 2008-09-11 | Kiehne Bruce L | Syringe with rear plunger lock |
DE202007005394U1 (en) | 2007-04-13 | 2007-08-09 | B. Braun Melsungen Ag | Safety nozzle, has piston rod whose release movement is enabled in distal direction relative to nozzle cylinder during attachment of piston to distal front wall of piston rod, in order to release retaining flange |
KR100884689B1 (en) | 2007-07-27 | 2009-02-18 | 최종수 | Needle Assembly for Injector |
GB0800103D0 (en) | 2008-01-04 | 2008-02-13 | Owen Mumford Ltd | Sheath removver device |
GB0802351D0 (en) | 2008-02-08 | 2008-03-12 | Owen Mumford Ltd | Injection devices |
US8172813B2 (en) | 2008-02-28 | 2012-05-08 | Becton, Dickinson And Company | Syringe with two piece plunger rod |
GB0814747D0 (en) | 2008-08-13 | 2008-09-17 | Owen Mumford Ltd | Autoinjection devices |
ES2736182T3 (en) | 2008-09-18 | 2019-12-26 | Becton Dickinson Co | Medical injector with attached body parts |
WO2011022605A1 (en) | 2009-08-21 | 2011-02-24 | Becton Dickinson France Sas | Magnifying collapsed plunger rod |
US8535278B2 (en) | 2010-02-11 | 2013-09-17 | Allergan, Inc. | Extendable plunger rod for medical syringe |
CN101862490B (en) * | 2010-06-21 | 2012-07-11 | 温岭市千禧光医疗器械有限公司 | Self-destruction insulin syringe capable of replacing needle |
US9101719B2 (en) | 2010-10-29 | 2015-08-11 | Becton Dickinson France | Piston rod for a container |
JP5897034B2 (en) | 2010-12-14 | 2016-03-30 | ベクトン ディキンソン フランス | Compact injection device |
US8961470B2 (en) | 2011-02-17 | 2015-02-24 | Steven Schraga | Pen needle with safety shield system |
US8491535B2 (en) | 2011-04-28 | 2013-07-23 | Becton, Dickinson And Company | Safety pen needle assembly |
US9078975B2 (en) | 2011-09-30 | 2015-07-14 | Becton Dickinson France, S.A.S. | Syringe having pivoting arm plunger rod |
US9597455B2 (en) | 2011-09-30 | 2017-03-21 | Becton Dickinson France S.A.S. | Syringe having a spring action plunger rod |
US9078974B2 (en) | 2011-09-30 | 2015-07-14 | Becton Dickinson France, S.A.S. | Syringe having dual pivoting arm plunger rod |
US8882719B2 (en) | 2011-09-30 | 2014-11-11 | Becton Dickinson France S.A.S. | Syringe having a removable cover for use as a plunger rod in rotational engagement |
US8657793B2 (en) | 2011-09-30 | 2014-02-25 | Becton Dickinson France, S.A.S | Space saving plunger cap and rod assembly |
US9333288B2 (en) | 2011-09-30 | 2016-05-10 | Becton Dickinson France, S.A.S. | Attachable plunger rod and associated packaging |
US9937299B2 (en) | 2013-09-26 | 2018-04-10 | Becton, Dickinson And Company | Adjustable penetration depth syringe |
WO2015117131A1 (en) | 2014-02-03 | 2015-08-06 | Unitract Syringe Pty Ltd | Expanding plunger rods for syringes |
US9339606B2 (en) | 2014-05-15 | 2016-05-17 | West Pharmaceutical Services, Inc. | Foldable finger flange for a syringe |
WO2016115628A1 (en) | 2015-01-20 | 2016-07-28 | L.O.M. Laboratories Inc. | Retractable needle syringe with unitary propellant release module |
US9681889B1 (en) | 2015-06-09 | 2017-06-20 | Surgentec, Llc | Depth controlled needle assembly |
CH711656A2 (en) | 2015-10-19 | 2017-04-28 | Tecpharma Licensing Ag | Device for administering an active substance and method for operating this device. |
USD787673S1 (en) | 2015-11-09 | 2017-05-23 | Edgewell Personal Care Brands, Llc | Telescoping plunger |
USD772409S1 (en) | 2015-11-09 | 2016-11-22 | Edgewell Personal Care Brands, Llc | Applicator with telescoping plunger |
TW201731539A (en) | 2015-11-27 | 2017-09-16 | 賽諾菲阿凡提斯德意志有限公司 | Auto-injector |
US10898658B2 (en) | 2016-07-06 | 2021-01-26 | LynJohnston, LLC | Compact injection device with telescoping components |
-
2019
- 2019-01-10 JP JP2020538983A patent/JP7304354B2/en active Active
- 2019-01-10 EP EP19738322.7A patent/EP3737443A4/en active Pending
- 2019-01-10 MX MX2020007385A patent/MX2020007385A/en unknown
- 2019-01-10 AU AU2019206534A patent/AU2019206534A1/en active Pending
- 2019-01-10 US US16/961,636 patent/US11607502B2/en active Active
- 2019-01-10 WO PCT/US2019/013017 patent/WO2019140067A1/en unknown
- 2019-01-10 CN CN201980012788.9A patent/CN111836658B/en active Active
- 2019-01-10 CA CA3088158A patent/CA3088158A1/en active Pending
-
2023
- 2023-03-20 US US18/186,502 patent/US20240091461A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7357790B2 (en) * | 2003-12-18 | 2008-04-15 | Tecpharma Licensing Ag | Auto-injector with active agent container latching |
US20130082057A1 (en) * | 2011-09-30 | 2013-04-04 | Becton Dickinson France, S.A.S. | Syringe Assembly Having a Telescoping Plunger Rod |
Also Published As
Publication number | Publication date |
---|---|
AU2019206534A1 (en) | 2020-07-30 |
WO2019140067A1 (en) | 2019-07-18 |
MX2020007385A (en) | 2020-11-24 |
CN111836658B (en) | 2022-07-08 |
JP7304354B2 (en) | 2023-07-06 |
EP3737443A1 (en) | 2020-11-18 |
EP3737443A4 (en) | 2021-10-27 |
JP2021510340A (en) | 2021-04-22 |
CA3088158A1 (en) | 2019-07-18 |
US20200338276A1 (en) | 2020-10-29 |
US11607502B2 (en) | 2023-03-21 |
CN111836658A (en) | 2020-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240091461A1 (en) | Compact injector systems and methods | |
US5330440A (en) | Reverse thread carpule dental safety syringe | |
USRE37439E1 (en) | Disposable self-shielding aspirating syringe | |
US5593391A (en) | Ampule safety syringe | |
JP6047486B2 (en) | Needle shield for safety device, safety device and injection device | |
CN108837242B (en) | Passive protective needle device | |
JP5030593B2 (en) | Safety shield system for prefilled syringes | |
US7717888B2 (en) | Safety needle with collapsible sheath | |
US5403288A (en) | Safety sleeve for dental syringe | |
US6966899B2 (en) | Hand-piece for injection device with a retractable and rotating needle | |
US5279582A (en) | Retractable syringe sheath with bottle engagement | |
EP0369619A1 (en) | Disposable sheath for hypodermic cannula used with a syringe | |
US20140221971A1 (en) | Injector for auto-injection of medication and associated method of use | |
US6485469B1 (en) | Shielded dental safety needle | |
US5037402A (en) | Dual-chamber safety syringe | |
JP2003522609A (en) | Automatically actuated safety shield system for syringes | |
PT1604700E (en) | Needle tip guard for hypodermic needles | |
JP2018086320A (en) | Preventing reuse of needle of needle assembly for drug delivery device | |
MX2012015039A (en) | Safety device for a pre-filled syringe and injection device. | |
JP5990221B2 (en) | Anesthetic syringe | |
CA3078916C (en) | Needle shield puller for drug delivery system | |
EP4233939A2 (en) | Safety needle device | |
MX2014011004A (en) | Retracting sheath detachable safety needle with moving spring. | |
US20040116864A1 (en) | Catheter introducer assembly having safety shielded needle before and after use | |
WO2021170647A1 (en) | Injection device incorporating a needle shield remover |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LYNJOHNSTON, LLC, MONTANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WALLER, LINDA J.;HENNINGE, PAUL C.;SIGNING DATES FROM 20180315 TO 20180319;REEL/FRAME:063119/0783 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |